CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | EC 1.14.14.* (oxidoreductase acting on paired donors, incorporating of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor) inhibitor |
|
Accession: | CHEBI:76838
|
browse the term
|
Definition: | An EC 1.14.* (oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor that interferes with the action of any such enzyme incorporating one atom of oxygen and using reduced flavin or flavoprotein as donor (EC 1.14.14.*). |
Synonyms: | related_synonym: | EC 1.14.14.* (oxidoreductase acting on paired donors, incorporating of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor) inhibitors; EC 1.14.14.* (oxidoreductase acting on paired donors, with incorporation of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor) inhibitor; EC 1.14.14.* (oxidoreductase acting on paired donors, with incorporation of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor) inhibitors; EC 1.14.14.* inhibitor; EC 1.14.14.* inhibitors |
|
|
|
G |
Acat1 |
acetyl-Coenzyme A acetyltransferase 1 |
multiple interactions |
EXP |
1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of ACAT1 protein] |
CTD |
PMID:32435916 |
|
NCBI chr 9:53,491,822...53,521,650
Ensembl chr 9:53,491,822...53,521,682
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
ISO |
1-aminobenzotriazole inhibits the reaction [Chlorpyrifos metabolite results in decreased activity of ACHE protein] |
CTD |
PMID:30625376 |
|
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
multiple interactions |
EXP |
1-aminobenzotriazole affects the reaction [propylene dichloride results in increased expression of ACOT2 protein] |
CTD |
PMID:32435916 |
|
NCBI chr12:84,034,635...84,040,651
Ensembl chr12:84,034,635...84,040,647
|
|
G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
multiple interactions |
EXP |
1-aminobenzotriazole affects the reaction [propylene dichloride results in increased expression of ALDH1B1 protein] |
CTD |
PMID:32435916 |
|
NCBI chr 4:45,799,022...45,804,608
Ensembl chr 4:45,799,022...45,804,604
|
|
G |
Car3 |
carbonic anhydrase 3 |
multiple interactions |
EXP |
1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of CAR3 protein] |
CTD |
PMID:32435916 |
|
NCBI chr 3:14,928,598...14,937,441
Ensembl chr 3:14,928,572...14,937,583
|
|
G |
Cd86 |
CD86 antigen |
multiple interactions |
ISO |
1-aminobenzotriazole inhibits the reaction [Benzo(a)pyrene results in increased expression of CD86 protein] |
CTD |
PMID:21742781 |
|
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
|
|
G |
Ces3a |
carboxylesterase 3A |
multiple interactions |
EXP |
1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of CES3A protein] |
CTD |
PMID:32435916 |
|
NCBI chr 8:105,775,208...105,788,560
Ensembl chr 8:105,775,233...105,785,045
|
|
G |
Ces3b |
carboxylesterase 3B |
multiple interactions |
EXP |
1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of CES3B protein] |
CTD |
PMID:32435916 |
|
NCBI chr 8:105,810,365...105,820,561
Ensembl chr 8:105,810,385...105,820,561
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression |
ISO |
1-aminobenzotriazole inhibits the reaction [Skatole results in increased expression of CYP1A1 mRNA] 1-aminobenzotriazole results in increased expression of CYP1A1 protein 1-aminobenzotriazole inhibits the reaction [Oxygen results in increased activity of CYP1A1 protein]; [1-aminobenzotriazole co-treated with Oxygen] results in increased activity of CYP1A1 protein |
CTD |
PMID:10640292 PMID:20187624 |
|
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions increases expression decreases activity |
ISO |
[1-aminobenzotriazole co-treated with Oxygen] results in increased activity of CYP1A2 protein; [Oxygen co-treated with 1-aminobenzotriazole] results in increased expression of CYP1A2 protein 1-aminobenzotriazole results in increased expression of CYP1A2 protein 1-aminobenzotriazole results in decreased activity of CYP1A2 protein |
CTD |
PMID:10640292 PMID:15618748 |
|
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
|
|
G |
Cyp2c65 |
cytochrome P450, family 2, subfamily c, polypeptide 65 |
decreases activity multiple interactions |
ISO |
1-aminobenzotriazole results in decreased activity of CYP2C9 protein 1-aminobenzotriazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] |
CTD |
PMID:11375247 PMID:15618748 |
|
NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
|
|
G |
Cyp2d22 |
cytochrome P450, family 2, subfamily d, polypeptide 22 |
multiple interactions decreases activity |
ISO |
1-aminobenzotriazole inhibits the reaction [CYP2D6 protein results in increased hydroxylation of bufuralol] 1-aminobenzotriazole results in decreased activity of CYP2D6 protein |
CTD |
PMID:11375247 PMID:15618748 |
|
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions decreases activity |
EXP ISO |
1-aminobenzotriazole inhibits the reaction [CYP2E1 protein affects the metabolism of Urethane]; 1-aminobenzotriazole inhibits the reaction [CYP2E1 protein results in increased oxidation of 1,3-butadiene] 1-aminobenzotriazole results in decreased activity of CYP2E1 protein 1-aminobenzotriazole inhibits the reaction [[[SULT1A1 protein co-treated with CYP2E1 protein] results in increased susceptibility to 1-methylpyrene] which results in increased mutagenesis of HPRT1 gene] |
CTD |
PMID:10828257 PMID:12704224 PMID:15618748 PMID:25243916 PMID:27421776 |
|
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
|
|
G |
Cyp2f2 |
cytochrome P450, family 2, subfamily f, polypeptide 2 |
multiple interactions |
ISO |
1-aminobenzotriazole inhibits the reaction [Skatole results in increased expression of CYP2F1 mRNA] |
CTD |
PMID:20187624 |
|
NCBI chr 7:26,819,380...26,833,085
Ensembl chr 7:26,819,334...26,833,085
|
|
G |
Cyp3a13 |
cytochrome P450, family 3, subfamily a, polypeptide 13 |
multiple interactions |
ISO |
1-aminobenzotriazole inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA] |
CTD |
PMID:24555085 |
|
NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
|
|
G |
Ech1 |
enoyl coenzyme A hydratase 1, peroxisomal |
multiple interactions |
EXP |
1-aminobenzotriazole affects the reaction [propylene dichloride results in increased expression of ECH1 protein] |
CTD |
PMID:32435916 |
|
NCBI chr 7:28,524,763...28,531,664
Ensembl chr 7:28,524,642...28,531,672
|
|
G |
Ftcd |
formiminotransferase cyclodeaminase |
multiple interactions |
EXP |
1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of FTCD protein] |
CTD |
PMID:32435916 |
|
NCBI chr10:76,411,482...76,426,172
Ensembl chr10:76,411,482...76,426,172
|
|
G |
Fth1 |
ferritin heavy polypeptide 1 |
multiple interactions |
EXP |
1-aminobenzotriazole inhibits the reaction [propylene dichloride results in increased expression of FTH1 protein] |
CTD |
PMID:32435916 |
|
NCBI chr19:9,957,964...9,962,475
Ensembl chr19:9,957,962...9,962,462
|
|
G |
Ftl1 |
ferritin light polypeptide 1 |
multiple interactions |
EXP |
1-aminobenzotriazole affects the reaction [propylene dichloride results in increased expression of FTL1 protein] |
CTD |
PMID:32435916 |
|
NCBI chr 7:45,107,368...45,109,310
Ensembl chr 7:45,107,368...45,109,308
|
|
G |
Gpt |
glutamic pyruvic transaminase, soluble |
multiple interactions |
EXP |
1-aminobenzotriazole inhibits the reaction [Acetaminophen results in increased activity of GPT protein]; 1-aminobenzotriazole promotes the reaction [Amiodarone promotes the reaction [Dexamethasone results in increased expression of GPT protein]]; [1-aminobenzotriazole co-treated with ochratoxin A] results in increased activity of GPT protein; [Emodin co-treated with 1-aminobenzotriazole] results in increased expression of GPT protein |
CTD |
PMID:25900201 PMID:34492313 PMID:36227364 |
|
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
|
|
G |
Gstm1 |
glutathione S-transferase, mu 1 |
multiple interactions |
EXP |
1-aminobenzotriazole affects the reaction [propylene dichloride results in increased expression of GSTM1 protein] |
CTD |
PMID:32435916 |
|
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions |
ISO |
1-aminobenzotriazole inhibits the reaction [captax results in increased expression of H2AX protein]; 1-aminobenzotriazole inhibits the reaction [propylene dichloride results in increased phosphorylation of H2AX protein]; 1-aminobenzotriazole inhibits the reaction [Trichloroethylene results in increased phosphorylation of H2AX protein] |
CTD |
PMID:28300663 PMID:29722447 PMID:35279910 |
|
NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
multiple interactions |
EXP |
[1-aminobenzotriazole co-treated with ochratoxin A] results in increased expression of HAVCR1 protein |
CTD |
PMID:36227364 |
|
NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
ISO |
1-aminobenzotriazole inhibits the reaction [[Acetaminophen co-treated with Buthionine Sulfoximine] results in increased expression of HMOX1 mRNA]; 1-aminobenzotriazole inhibits the reaction [[Butylated Hydroxyanisole co-treated with Buthionine Sulfoximine] results in increased expression of HMOX1 mRNA]; 1-aminobenzotriazole inhibits the reaction [[Diclofenac co-treated with Buthionine Sulfoximine] results in increased expression of HMOX1 mRNA]; 1-aminobenzotriazole inhibits the reaction [[Ticlopidine co-treated with Buthionine Sulfoximine] results in increased expression of HMOX1 mRNA] |
CTD |
PMID:18227147 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
multiple interactions |
ISO |
1-aminobenzotriazole inhibits the reaction [[[SULT1A1 protein co-treated with CYP2E1 protein] results in increased susceptibility to 1-methylpyrene] which results in increased mutagenesis of HPRT1 gene] |
CTD |
PMID:25243916 |
|
NCBI chr X:52,076,955...52,110,537
Ensembl chr X:52,077,014...52,110,536
|
|
G |
Inmt |
indolethylamine N-methyltransferase |
multiple interactions |
EXP |
1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of INMT protein] |
CTD |
PMID:32435916 |
|
NCBI chr 6:55,147,612...55,151,975
Ensembl chr 6:55,147,611...55,152,028
|
|
G |
Krt8 |
keratin 8 |
multiple interactions |
EXP |
1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of KRT8 protein] |
CTD |
PMID:32435916 |
|
NCBI chr15:101,905,146...101,912,777
Ensembl chr15:101,905,133...101,912,917
|
|
G |
Lcn2 |
lipocalin 2 |
multiple interactions |
EXP |
[1-aminobenzotriazole co-treated with ochratoxin A] results in increased expression of LCN2 protein |
CTD |
PMID:36227364 |
|
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
|
|
G |
Mup2 |
major urinary protein 2 |
multiple interactions |
EXP |
1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of MUP2 protein] |
CTD |
PMID:32435916 |
|
NCBI chr 4:60,135,913...60,139,977
Ensembl chr 4:60,135,932...60,154,289
|
|
G |
Rgn |
regucalcin |
multiple interactions |
EXP |
1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of RGN protein] |
CTD |
PMID:32435916 |
|
NCBI chr X:20,413,980...20,428,328
Ensembl chr X:20,416,026...20,428,328
|
|
G |
Selenbp2 |
selenium binding protein 2 |
multiple interactions |
EXP |
1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of SELENBP2 protein] |
CTD |
PMID:32435916 |
|
NCBI chr 3:94,600,880...94,611,713
Ensembl chr 3:94,600,863...94,611,720
|
|
G |
Ubp1 |
upstream binding protein 1 |
multiple interactions |
EXP |
1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of UBP1 protein] |
CTD |
PMID:32435916 |
|
NCBI chr 9:113,760,002...113,807,095
Ensembl chr 9:113,760,002...113,806,270
|
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
ISO |
1-phenylimidazole inhibits the reaction [[[[CYP2E1 protein results in increased oxidation of furan] which results in increased chemical synthesis of malealdehyde] which co-treated with Glutathione] results in increased glutathionylation of malealdehyde]; 1-phenylimidazole inhibits the reaction [CYP2E1 protein results in increased reduction of Tirapazamine] |
CTD |
PMID:7710944 PMID:21842885 |
|
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
|
|
|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
multiple interactions increases expression |
ISO |
[3,3'-diindolylmethane results in increased activity of NR1I2 protein] which results in increased expression of ABCB1 mRNA; Ketoconazole inhibits the reaction [3,3'-diindolylmethane results in increased expression of ABCB1 mRNA] |
CTD |
PMID:25542144 |
|
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
G |
Actg1 |
actin, gamma, cytoplasmic 1 |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Estradiol results in decreased expression of ACTG1 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr11:120,236,513...120,239,321
Ensembl chr11:120,236,516...120,239,368
|
|
G |
Adgre1 |
adhesion G protein-coupled receptor E1 |
multiple interactions |
EXP |
3,3'-diindolylmethane inhibits the reaction [Lipopolysaccharides results in increased expression of ADGRE1 mRNA] |
CTD |
PMID:24162184 |
|
NCBI chr17:57,665,650...57,790,527
Ensembl chr17:57,665,691...57,790,527
|
|
G |
Ahr |
aryl-hydrocarbon receptor |
affects response to substance affects localization multiple interactions |
ISO EXP |
AHR protein affects the susceptibility to 3,3'-diindolylmethane 3,3'-diindolylmethane affects the localization of AHR protein 3,3'-diindolylmethane binds to and results in decreased activity of AHR protein; 3,3'-diindolylmethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] 3,3'-diindolylmethane binds to and results in increased activity of AHR protein; 3,3'-diindolylmethane inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein] 3,3'-diindolylmethane binds to and results in increased activity of AHR protein; 3,3'-diindolylmethane inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PTGS2 promoter]]; 3,3'-diindolylmethane promotes the reaction [AHR protein binds to CYP1A1 promoter]; AHR mutant form inhibits the reaction [3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of HMOX1 mRNA]]; AHR mutant form inhibits the reaction [3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]] |
CTD |
PMID:8384853 PMID:9771935 PMID:11294972 PMID:16972788 PMID:19056653 PMID:19223575 PMID:20435555 PMID:23583297 More...
|
|
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
multiple interactions |
EXP |
3,3'-diindolylmethane inhibits the reaction [Lipopolysaccharides results in increased expression of AIF1 protein] |
CTD |
PMID:24162184 |
|
NCBI chr17:35,389,967...35,394,977
Ensembl chr17:35,389,967...35,395,044
|
|
G |
Ar |
androgen receptor |
decreases activity |
ISO |
3,3'-diindolylmethane results in decreased activity of AR protein |
CTD |
PMID:30247711 |
|
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [ARNT protein binds to CYP1A1 promoter] |
CTD |
PMID:16972788 |
|
NCBI chr 3:95,341,674...95,404,551
Ensembl chr 3:95,341,699...95,404,551
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of ATF3 |
CTD |
PMID:15670751 |
|
NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236
|
|
G |
Atp5f1a |
ATP synthase F1 subunit alpha |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of ATP5F1A mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr18:77,861,468...77,870,569
Ensembl chr18:77,861,429...77,870,569
|
|
G |
Bad |
BCL2-associated agonist of cell death |
decreases phosphorylation |
ISO |
3,3'-diindolylmethane results in decreased phosphorylation of BAD protein |
CTD |
PMID:22290291 |
|
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
|
|
G |
Bax |
BCL2-associated X protein |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of BAX protein |
CTD |
PMID:22290291 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bbc3 |
BCL2 binding component 3 |
multiple interactions |
ISO |
[3,3'-diindolylmethane results in increased phosphorylation of and results in increased activity of TP53 protein] which results in increased expression of BBC3 |
CTD |
PMID:22290291 |
|
NCBI chr 7:16,042,307...16,052,130
Ensembl chr 7:16,042,318...16,052,130
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions decreases expression |
ISO EXP |
3,3'-diindolylmethane promotes the reaction [Paclitaxel results in decreased expression of BCL2 protein] 3,3'-diindolylmethane analog results in decreased expression of BCL2 mRNA 3,3'-diindolylmethane analog results in decreased expression of BCL2 protein; 3,3'-diindolylmethane results in decreased expression of BCL2 protein |
CTD |
PMID:16051428 PMID:16580691 PMID:22290291 PMID:26593444 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bcl2l1 |
BCL2-like 1 |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of BCL2L1 mRNA; 3,3'-diindolylmethane results in increased expression of BCL2L1 protein |
CTD |
PMID:18025290 |
|
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
|
|
G |
Bcl2l10 |
Bcl2-like 10 |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of BCL2L10 mRNA |
CTD |
PMID:22514694 |
|
NCBI chr 9:75,255,040...75,258,922
Ensembl chr 9:75,255,040...75,258,931
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of BIRC5 protein |
CTD |
PMID:22290291 |
|
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
|
|
G |
Brd2 |
bromodomain containing 2 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of BRD2 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr17:34,330,993...34,341,581
Ensembl chr17:34,330,997...34,341,608
|
|
G |
Calm2 |
calmodulin 2 |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Estradiol results in decreased expression of CALM2 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr17:87,740,829...87,754,363
Ensembl chr17:87,740,840...87,754,363
|
|
G |
Casp3 |
caspase 3 |
increases activity |
EXP |
3,3'-diindolylmethane results in increased activity of CASP3 protein |
CTD |
PMID:21820497 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Ccn1 |
cellular communication network factor 1 |
affects methylation |
ISO |
3,3'-diindolylmethane affects the methylation of CCN1 promoter |
CTD |
PMID:24466240 |
|
NCBI chr 3:145,352,726...145,355,740
Ensembl chr 3:145,352,731...145,355,736
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of CCNB1 |
CTD |
PMID:22290291 |
|
NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression multiple interactions |
ISO |
3,3'-diindolylmethane analog results in decreased expression of CCND1 protein; 3,3'-diindolylmethane results in decreased expression of CCND1 protein benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [3,3'-diindolylmethane analog results in decreased expression of CCND1 protein] |
CTD |
PMID:16051428 PMID:22290291 |
|
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
|
|
G |
Ccnd3 |
cyclin D3 |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of CCND3 protein |
CTD |
PMID:22514694 |
|
NCBI chr17:47,815,976...47,910,614
Ensembl chr17:47,815,976...47,910,616
|
|
G |
Ccr4 |
C-C motif chemokine receptor 4 |
affects methylation |
ISO |
3,3'-diindolylmethane affects the methylation of CCR4 promoter |
CTD |
PMID:24466240 |
|
NCBI chr 9:114,319,384...114,334,544
Ensembl chr 9:114,319,384...114,333,984
|
|
G |
Cd40lg |
CD40 ligand |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of CD40LG mRNA |
CTD |
PMID:22514694 |
|
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
|
|
G |
Cd69 |
CD69 antigen |
multiple interactions |
EXP |
3,3'-diindolylmethane inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of CD69 protein] |
CTD |
PMID:24200994 |
|
NCBI chr 6:129,244,287...129,252,332
Ensembl chr 6:129,244,288...129,252,399
|
|
G |
Cdc25c |
cell division cycle 25C |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of CDC25C |
CTD |
PMID:22290291 |
|
NCBI chr18:34,866,046...34,884,644
Ensembl chr18:34,866,046...34,884,586
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [bisphenol A results in decreased expression of CDH1 protein]; 3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of CDH1 protein]; 3,3'-diindolylmethane inhibits the reaction [Triclosan results in decreased expression of CDH1 protein] |
CTD |
PMID:28844962 |
|
NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
|
|
G |
Cdh11 |
cadherin 11 |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of CDH11 protein |
CTD |
PMID:18025290 |
|
NCBI chr 8:103,358,727...103,512,125
Ensembl chr 8:103,358,727...103,512,274
|
|
G |
Cdh2 |
cadherin 2 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [bisphenol A results in increased expression of CDH2 protein]; 3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of CDH2 protein]; 3,3'-diindolylmethane inhibits the reaction [Triclosan results in increased expression of CDH2 protein] |
CTD |
PMID:28844962 |
|
NCBI chr18:16,721,934...16,942,303
Ensembl chr18:16,721,934...16,942,303
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
multiple interactions decreases activity |
ISO |
3,3'-diindolylmethane promotes the reaction [CDK2 protein binds to CDKN1A protein] 3,3'-diindolylmethane results in decreased activity of CDK2 protein |
CTD |
PMID:15611077 |
|
NCBI chr10:128,533,807...128,540,920
Ensembl chr10:128,533,808...128,540,900
|
|
G |
Cdk4 |
cyclin dependent kinase 4 |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of CDK4 protein |
CTD |
PMID:22514694 |
|
NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789
|
|
G |
Cdk6 |
cyclin dependent kinase 6 |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of CDK6 protein |
CTD |
PMID:22290291 PMID:22514694 |
|
NCBI chr 5:3,391,004...3,581,008
Ensembl chr 5:3,391,485...3,581,008
|
|
G |
Cdkn1a |
cyclin dependent kinase inhibitor 1A |
multiple interactions increases expression |
ISO |
3,3'-diindolylmethane promotes the reaction [CDK2 protein binds to CDKN1A protein] 3,3'-diindolylmethane results in increased expression of CDKN1A mRNA; 3,3'-diindolylmethane results in increased expression of CDKN1A protein |
CTD |
PMID:12203118 PMID:15611077 PMID:18025290 PMID:22290291 PMID:22495798 |
|
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
|
|
G |
Cdkn1b |
cyclin dependent kinase inhibitor 1B |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of CDKN1B protein |
CTD |
PMID:22290291 |
|
NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
|
|
G |
Cdkn2d |
cyclin dependent kinase inhibitor 2D |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of CDKN2D protein |
CTD |
PMID:22290291 |
|
NCBI chr 9:21,199,759...21,202,553
Ensembl chr 9:21,199,706...21,202,703
|
|
G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
decreases phosphorylation |
ISO |
3,3'-diindolylmethane results in decreased phosphorylation of CHUK protein |
CTD |
PMID:22290291 |
|
NCBI chr19:44,061,773...44,095,940
Ensembl chr19:44,061,774...44,095,919
|
|
G |
Cks1b |
CDC28 protein kinase 1b |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Estradiol results in decreased expression of CKS1B mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 3:89,322,779...89,325,598
Ensembl chr 3:89,322,779...89,325,690
|
|
G |
Ctsb |
cathepsin B |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [bisphenol A results in increased expression of CTSB protein]; 3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of CTSB protein]; 3,3'-diindolylmethane inhibits the reaction [Triclosan results in increased expression of CTSB protein] |
CTD |
PMID:28844962 |
|
NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372
|
|
G |
Ctsd |
cathepsin D |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [bisphenol A results in increased expression of CTSD protein]; 3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of CTSD protein]; 3,3'-diindolylmethane inhibits the reaction [Triclosan results in increased expression of CTSD protein] |
CTD |
PMID:28844962 |
|
NCBI chr 7:141,929,647...141,941,564
Ensembl chr 7:141,929,648...141,941,775
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
affects methylation multiple interactions |
ISO |
3,3'-diindolylmethane affects the methylation of CXCR4 promoter 3,3'-diindolylmethane inhibits the reaction [bisphenol A results in increased expression of CXCR4 protein]; 3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of CXCR4 protein]; 3,3'-diindolylmethane inhibits the reaction [Triclosan results in increased expression of CXCR4 protein] |
CTD |
PMID:24466240 PMID:28844962 |
|
NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO |
3,3'-diindolylmethane analog affects the localization of and results in increased expression of CYCS protein |
CTD |
PMID:16051428 |
|
NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
increases expression |
ISO |
3,3'-diindolylmethane analog results in increased expression of CYP19A1 mRNA; 3,3'-diindolylmethane results in increased expression of CYP19A1 mRNA |
CTD |
PMID:11294972 |
|
NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases activity increases expression decreases activity |
ISO |
3,3'-diindolylmethane promotes the reaction [AHR protein binds to CYP1A1 promoter]; 3,3'-diindolylmethane promotes the reaction [ARNT protein binds to CYP1A1 promoter]; 3,3'-diindolylmethane promotes the reaction [ESR1 protein binds to CYP1A1 promoter]; [3,3'-diindolylmethane results in increased expression of CYP1A1 mRNA] which results in increased abundance of aflatoxin B1-DNA adduct 3,3'-diindolylmethane analog results in increased activity of CYP1A1 protein; 3,3'-diindolylmethane results in increased activity of CYP1A1 protein 3,3'-diindolylmethane results in increased expression of CYP1A1 protein 3,3'-diindolylmethane analog results in increased expression of CYP1A1 mRNA; 3,3'-diindolylmethane results in increased expression of CYP1A1 mRNA; 3,3'-diindolylmethane results in increased expression of CYP1A1 protein 3,3'-diindolylmethane results in decreased activity of CYP1A1 protein |
CTD |
PMID:8384853 PMID:9771935 PMID:11179685 PMID:11294972 PMID:11597580 PMID:15672752 PMID:16972788 PMID:19770484 PMID:22495798 PMID:23583297 More...
|
|
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions increases expression decreases activity increases oxidation |
ISO |
[3,3'-diindolylmethane results in increased expression of CYP1A2 mRNA] which results in increased abundance of aflatoxin B1-DNA adduct; Quercetin inhibits the reaction [CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane]; resveratrol inhibits the reaction [CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane] 3,3'-diindolylmethane results in increased expression of CYP1A2 protein 3,3'-diindolylmethane results in increased expression of CYP1A2 mRNA; 3,3'-diindolylmethane results in increased expression of CYP1A2 protein 3,3'-diindolylmethane results in decreased activity of CYP1A2 protein |
CTD |
PMID:8384853 PMID:15672752 PMID:16544949 PMID:19770484 |
|
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression |
ISO |
3,3'-diindolylmethane analog results in increased expression of CYP1B1 mRNA; 3,3'-diindolylmethane results in increased expression of CYP1B1 mRNA |
CTD |
PMID:11294972 |
|
NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
|
|
G |
Cyp2b13 |
cytochrome P450, family 2, subfamily b, polypeptide 13 |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of CYP2B2 protein |
CTD |
PMID:8384853 |
|
NCBI chr 7:25,760,813...25,795,622
Ensembl chr 7:25,760,922...25,795,622
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of DDIT3 protein |
CTD |
PMID:22290291 |
|
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of DNMT1 mRNA |
CTD |
PMID:24466240 |
|
NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184
|
|
G |
Dnmt3b |
DNA methyltransferase 3B |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of DNMT3B mRNA |
CTD |
PMID:24466240 |
|
NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650
|
|
G |
Eef1g |
eukaryotic translation elongation factor 1 gamma |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Estradiol results in increased expression of EEF1G mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr19:8,944,405...8,955,544
Ensembl chr19:8,944,405...8,955,843
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Paclitaxel results in decreased phosphorylation of and results in decreased activity of ERBB2 protein]; 3,3'-diindolylmethane results in decreased phosphorylation of and results in decreased activity of ERBB2 protein |
CTD |
PMID:16580691 |
|
NCBI chr11:98,303,310...98,328,542
Ensembl chr11:98,303,296...98,328,542
|
|
G |
Esr1 |
estrogen receptor 1 (alpha) |
multiple interactions decreases expression |
ISO |
3,3'-diindolylmethane binds to and results in increased activity of ESR1 protein; 3,3'-diindolylmethane promotes the reaction [ESR1 protein binds to CYP1A1 promoter]; 3,3'-diindolylmethane promotes the reaction [ESR1 protein binds to TFF1 promoter]; ESR1 mutant form promotes the reaction [3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of HMOX1 mRNA]] 3,3'-diindolylmethane results in decreased expression of ESR1 |
CTD |
PMID:16972788 PMID:19223575 PMID:23583297 |
|
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
|
|
G |
Esr2 |
estrogen receptor 2 (beta) |
multiple interactions increases expression |
ISO |
3,3'-diindolylmethane promotes the reaction [ESR2 protein binds to KRT19 promoter]; 3,3'-diindolylmethane promotes the reaction [ESR2 protein binds to TMEM121B promoter]; ESR2 affects the reaction [3,3'-diindolylmethane promotes the reaction [NCOA2 protein binds to KRT19 promoter]]; ESR2 affects the reaction [3,3'-diindolylmethane results in increased expression of KRT19 mRNA]; ESR2 affects the reaction [3,3'-diindolylmethane results in increased expression of TMEM121B mRNA]; Raloxifene Hydrochloride inhibits the reaction [3,3'-diindolylmethane results in increased expression of ESR2 mRNA]; Tamoxifen inhibits the reaction [3,3'-diindolylmethane results in increased expression of ESR2 mRNA] |
CTD |
PMID:20160136 |
|
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
|
|
G |
Fau |
FAU ubiquitin like and ribosomal protein S30 fusion |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Estradiol results in decreased expression of FAU mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr19:6,107,977...6,109,554
Ensembl chr19:6,107,874...6,109,554
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of GDF15 mRNA |
CTD |
PMID:15670751 |
|
NCBI chr 8:71,082,043...71,085,106
Ensembl chr 8:71,082,043...71,085,106
|
|
G |
Gnas |
GNAS complex locus |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of GNAS mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 2:174,126,113...174,188,537
Ensembl chr 2:174,126,113...174,188,537
|
|
G |
Greb1 |
gene regulated by estrogen in breast cancer protein |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of GREB1 mRNA |
CTD |
PMID:23583297 |
|
NCBI chr12:16,720,616...16,851,395
Ensembl chr12:16,720,616...16,850,887
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
decreases phosphorylation |
ISO |
3,3'-diindolylmethane results in decreased phosphorylation of GSK3B protein |
CTD |
PMID:22290291 |
|
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
|
|
G |
Gstm1 |
glutathione S-transferase, mu 1 |
decreases expression multiple interactions |
ISO |
3,3'-diindolylmethane results in decreased expression of GSTM1 mRNA [3,3'-diindolylmethane results in decreased expression of GSTM1 mRNA] which results in increased abundance of aflatoxin B1-DNA adduct |
CTD |
PMID:19770484 |
|
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
|
|
G |
H3f3a |
H3.3 histone A |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Estradiol results in increased expression of H3-3A mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 1:180,630,125...180,641,127
Ensembl chr 1:180,628,397...180,641,508
|
|
G |
Hdac1 |
histone deacetylase 1 |
multiple interactions |
EXP |
3,3'-diindolylmethane inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of HDAC1 mRNA] |
CTD |
PMID:24200994 |
|
NCBI chr 4:129,409,897...129,436,516
Ensembl chr 4:129,409,897...129,436,506
|
|
G |
Hdac10 |
histone deacetylase 10 |
multiple interactions |
EXP |
3,3'-diindolylmethane promotes the reaction [enterotoxin B, staphylococcal results in decreased expression of HDAC10 mRNA] |
CTD |
PMID:24200994 |
|
NCBI chr15:89,007,506...89,012,903
Ensembl chr15:89,007,510...89,012,903
|
|
G |
Hdac2 |
histone deacetylase 2 |
decreases expression multiple interactions |
ISO EXP |
3,3'-diindolylmethane results in decreased expression of HDAC2 protein 3,3'-diindolylmethane inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of HDAC2 mRNA] |
CTD |
PMID:22800507 PMID:24200994 |
|
NCBI chr10:36,850,293...36,877,885
Ensembl chr10:36,850,540...36,877,885
|
|
G |
Hdac5 |
histone deacetylase 5 |
multiple interactions |
EXP |
3,3'-diindolylmethane promotes the reaction [enterotoxin B, staphylococcal results in decreased expression of HDAC5 mRNA] |
CTD |
PMID:24200994 |
|
NCBI chr11:102,085,244...102,120,968
Ensembl chr11:102,085,258...102,120,992
|
|
G |
Hdac8 |
histone deacetylase 8 |
multiple interactions |
EXP |
3,3'-diindolylmethane inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of HDAC8 mRNA] |
CTD |
PMID:24200994 |
|
NCBI chr X:101,328,244...101,549,005
Ensembl chr X:101,328,245...101,548,965
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of HMOX1 mRNA]; AHR mutant form inhibits the reaction [3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of HMOX1 mRNA]]; ESR1 mutant form promotes the reaction [3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of HMOX1 mRNA]] |
CTD |
PMID:23583297 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hrk |
harakiri, BCL2 interacting protein (contains only BH3 domain) |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of HRK mRNA |
CTD |
PMID:22514694 |
|
NCBI chr 5:118,307,829...118,327,543
Ensembl chr 5:118,302,713...118,327,543
|
|
G |
Hspa5 |
heat shock protein 5 |
decreases expression multiple interactions |
ISO |
3,3'-diindolylmethane analog results in decreased expression of HSPA5 protein 3,3'-diindolylmethane analog promotes the reaction [HSPA5 protein affects the expression of and affects the activity of MMP9 protein] |
CTD |
PMID:25794856 |
|
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
|
|
G |
Hspb1 |
heat shock protein 1 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of HSPB1 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 5:135,916,773...135,918,417
Ensembl chr 5:135,916,773...135,918,417
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
EXP |
3,3'-diindolylmethane inhibits the reaction [enterotoxin B, staphylococcal results in increased secretion of IFNG protein] |
CTD |
PMID:24200994 |
|
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
EXP |
3,3'-diindolylmethane inhibits the reaction [enterotoxin B, staphylococcal results in increased secretion of IL2 protein] |
CTD |
PMID:24200994 |
|
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO EXP |
3,3'-diindolylmethane results in increased expression of IL6 mRNA 3,3'-diindolylmethane inhibits the reaction [enterotoxin B, staphylococcal results in increased secretion of IL6 protein] |
CTD |
PMID:18025290 PMID:24200994 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Kdr |
kinase insert domain protein receptor |
decreases expression |
ISO |
3,3'-diindolylmethane analog results in decreased expression of KDR protein |
CTD |
PMID:25794856 |
|
NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118
|
|
G |
Klf10 |
Kruppel-like transcription factor 10 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of KLF10 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr15:38,291,702...38,300,950
Ensembl chr15:38,291,707...38,300,950
|
|
G |
Krt18 |
keratin 18 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of KRT18 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr15:101,936,651...101,940,461
Ensembl chr15:101,936,615...101,940,462
|
|
G |
Krt19 |
keratin 19 |
multiple interactions increases expression |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of KRT19 mRNA]; 3,3'-diindolylmethane promotes the reaction [ESR2 protein binds to KRT19 promoter]; 3,3'-diindolylmethane promotes the reaction [NCOA2 protein binds to KRT19 promoter]; ESR2 affects the reaction [3,3'-diindolylmethane promotes the reaction [NCOA2 protein binds to KRT19 promoter]]; ESR2 affects the reaction [3,3'-diindolylmethane results in increased expression of KRT19 mRNA]; NCOA2 mutant form inhibits the reaction [3,3'-diindolylmethane results in increased expression of KRT19 mRNA] |
CTD |
PMID:11179685 PMID:20160136 |
|
NCBI chr11:100,031,636...100,036,752
Ensembl chr11:100,031,636...100,039,491
|
|
G |
Magea9 |
MAGE family member A9 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of MAGEA9 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr X:63,217,154...63,222,385
Ensembl chr X:63,217,154...63,222,384
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [3,3'-diindolylmethane results in decreased phosphorylation of MAPK1 protein]; 3,3'-diindolylmethane promotes the reaction [Paclitaxel results in decreased phosphorylation of and results in decreased activity of MAPK1 protein]; 3,3'-diindolylmethane results in decreased phosphorylation of and results in decreased activity of MAPK1 protein |
CTD |
PMID:16580691 PMID:22290291 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
decreases phosphorylation multiple interactions |
ISO |
3,3'-diindolylmethane results in decreased phosphorylation of MAPK3 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [3,3'-diindolylmethane results in decreased phosphorylation of MAPK3 protein]; 3,3'-diindolylmethane promotes the reaction [Paclitaxel results in decreased phosphorylation of and results in decreased activity of MAPK3 protein]; 3,3'-diindolylmethane results in decreased phosphorylation of and results in decreased activity of MAPK3 protein |
CTD |
PMID:16580691 PMID:22290291 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mdm2 |
transformed mouse 3T3 cell double minute 2 |
decreases expression |
EXP |
3,3'-diindolylmethane analog results in decreased expression of MDM2 mRNA |
CTD |
PMID:26593444 |
|
NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [bisphenol A results in increased expression of MMP2 protein]; 3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of MMP2 protein]; 3,3'-diindolylmethane inhibits the reaction [Triclosan results in increased expression of MMP2 protein] |
CTD |
PMID:28844962 |
|
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO |
3,3'-diindolylmethane analog promotes the reaction [HSPA5 protein affects the expression of and affects the activity of MMP9 protein]; 3,3'-diindolylmethane analog results in decreased expression of and results in decreased activity of MMP9 protein; 3,3'-diindolylmethane inhibits the reaction [bisphenol A results in increased expression of MMP9 protein]; 3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of MMP9 protein]; 3,3'-diindolylmethane inhibits the reaction [Triclosan results in increased expression of MMP9 protein] |
CTD |
PMID:25794856 PMID:28844962 |
|
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
|
|
G |
mt-Co2 |
cytochrome c oxidase II, mitochondrial |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of COX2 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr MT:7,013...7,696
Ensembl chr MT:7,013...7,696
|
|
G |
Myb |
myeloblastosis oncogene |
decreases expression |
EXP |
3,3'-diindolylmethane analog results in decreased expression of MYB mRNA |
CTD |
PMID:26593444 |
|
NCBI chr10:21,000,829...21,036,883
Ensembl chr10:21,000,834...21,036,883
|
|
G |
Myc |
myelocytomatosis oncogene |
decreases expression |
ISO EXP |
3,3'-diindolylmethane results in decreased expression of MYC protein 3,3'-diindolylmethane analog results in decreased expression of MYC mRNA |
CTD |
PMID:22290291 PMID:26593444 |
|
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
|
|
G |
Myl6 |
myosin, light polypeptide 6, alkali, smooth muscle and non-muscle |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of MYL6 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr10:128,326,728...128,329,755
Ensembl chr10:128,326,729...128,330,014
|
|
G |
Ncoa2 |
nuclear receptor coactivator 2 |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [NCOA2 protein binds to KRT19 promoter]; ESR2 affects the reaction [3,3'-diindolylmethane promotes the reaction [NCOA2 protein binds to KRT19 promoter]]; NCOA2 mutant form inhibits the reaction [3,3'-diindolylmethane results in increased expression of KRT19 mRNA]; NCOA2 mutant form inhibits the reaction [3,3'-diindolylmethane results in increased expression of TMEM121B mRNA] |
CTD |
PMID:20160136 |
|
NCBI chr 1:13,209,329...13,444,451
Ensembl chr 1:13,209,329...13,444,307
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
increases expression multiple interactions |
ISO |
3,3'-diindolylmethane results in increased expression of NFE2L2 mRNA; 3,3'-diindolylmethane results in increased expression of NFE2L2 protein sulforaphane promotes the reaction [3,3'-diindolylmethane results in increased expression of NFE2L2 mRNA]; sulforaphane promotes the reaction [3,3'-diindolylmethane results in increased expression of NFE2L2 protein] |
CTD |
PMID:23583297 |
|
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
multiple interactions |
EXP |
3,3'-diindolylmethane inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] |
CTD |
PMID:24162184 |
|
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
multiple interactions increases expression |
ISO |
3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]; AHR mutant form inhibits the reaction [3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]] 3,3'-diindolylmethane results in increased expression of NQO1 mRNA |
CTD |
PMID:15672752 PMID:22495798 PMID:23583297 |
|
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity multiple interactions |
ISO |
3,3'-diindolylmethane results in increased activity of NR1I2 protein [3,3'-diindolylmethane results in increased activity of NR1I2 protein] which results in increased expression of ABCB1 mRNA; [3,3'-diindolylmethane results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA |
CTD |
PMID:25542144 |
|
NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
|
|
G |
Numa1 |
nuclear mitotic apparatus protein 1 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of NUMA1 protein] |
CTD |
PMID:26251508 |
|
NCBI chr 7:101,583,169...101,664,166
Ensembl chr 7:101,583,318...101,664,171
|
|
G |
Nup133 |
nucleoporin 133 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of NUP133 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 8:124,623,862...124,676,019
Ensembl chr 8:124,623,862...124,676,004
|
|
G |
Papola |
poly (A) polymerase alpha |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of PAPOLA mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr12:105,750,926...105,805,208
Ensembl chr12:105,750,953...105,805,203
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
multiple interactions |
ISO |
[3,3'-diindolylmethane co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of PARP1 protein |
CTD |
PMID:16580691 |
|
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
|
|
G |
Plau |
plasminogen activator, urokinase |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of PLAU mRNA |
CTD |
PMID:18025290 |
|
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
|
|
G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
multiple interactions |
ISO |
[3,3'-diindolylmethane results in increased phosphorylation of and results in increased activity of TP53 protein] which results in increased expression of PMAIP1 |
CTD |
PMID:22290291 |
|
NCBI chr18:66,591,675...66,598,629
Ensembl chr18:66,591,604...66,598,636
|
|
G |
Pten |
phosphatase and tensin homolog |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in decreased expression of PTEN protein] |
CTD |
PMID:26251508 |
|
NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions decreases expression |
ISO EXP |
3,3'-diindolylmethane inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PTGS2 promoter]]; 3,3'-diindolylmethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]; 3,3'-diindolylmethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 protein] 3,3'-diindolylmethane inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of PTGS2 protein] 3,3'-diindolylmethane inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] 3,3'-diindolylmethane results in decreased expression of PTGS2 mRNA; 3,3'-diindolylmethane results in decreased expression of PTGS2 protein |
CTD |
PMID:19056653 PMID:22290291 PMID:24162184 PMID:26251508 |
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
decreases expression multiple interactions |
ISO |
3,3'-diindolylmethane results in decreased expression of RELA protein 3,3'-diindolylmethane inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased phosphorylation of RELA protein] |
CTD |
PMID:22290291 PMID:26251508 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Ribc1 |
RIB43A domain with coiled-coils 1 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of RIBC1 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr X:150,787,576...150,799,884
Ensembl chr X:150,787,578...150,799,291
|
|
G |
Rpl10 |
ribosomal protein L10 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of RPL10 mRNA]; 3,3'-diindolylmethane promotes the reaction [Estradiol results in increased expression of RPL10 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr X:73,314,463...73,316,741
Ensembl chr X:73,314,418...73,316,741
|
|
G |
Rpl13a |
ribosomal protein L13A |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Estradiol results in increased expression of RPL13A mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 7:44,774,987...44,778,169
Ensembl chr 7:44,774,982...44,778,185
|
|
G |
Rpl31 |
ribosomal protein L31 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of RPL31 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 1:39,406,987...39,410,992
Ensembl chr 1:39,406,923...39,410,992
|
|
G |
Rpl41 |
ribosomal protein L41 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of RPL41 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr10:128,383,979...128,385,037
Ensembl chr10:128,383,983...128,385,174
|
|
G |
Rpl7 |
ribosomal protein L7 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of RPL7 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 1:16,171,519...16,174,657
Ensembl chr 1:16,171,519...16,174,886
|
|
G |
Rplp0 |
ribosomal protein lateral stalk subunit P0 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of RPLP0 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 5:115,697,526...115,701,788
Ensembl chr 5:115,697,526...115,701,786
|
|
G |
Rps15a |
ribosomal protein S15A |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of RPS15A mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 7:117,703,597...117,715,370
Ensembl chr 7:117,703,595...117,715,411
|
|
G |
Rps17 |
ribosomal protein S17 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of RPS17 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 7:80,992,481...80,994,982
Ensembl chr 7:80,992,480...80,995,002
|
|
G |
Rps3 |
ribosomal protein S3 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of RPS3 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 7:99,127,103...99,132,916
Ensembl chr 7:99,127,103...99,132,945
|
|
G |
Rps4x |
ribosomal protein S4, X-linked |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Estradiol results in increased expression of RPS4X mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr X:101,228,548...101,232,929
Ensembl chr X:101,228,547...101,233,000
|
|
G |
Rps6 |
ribosomal protein S6 |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Estradiol results in increased expression of RPS6 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 4:86,772,336...86,775,604
Ensembl chr 4:86,772,897...86,775,649
|
|
G |
Snai1 |
snail family zinc finger 1 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [bisphenol A results in increased expression of SNAI1 protein]; 3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of SNAI1 protein]; 3,3'-diindolylmethane inhibits the reaction [Triclosan results in increased expression of SNAI1 protein] |
CTD |
PMID:28844962 |
|
NCBI chr 2:167,380,115...167,384,734
Ensembl chr 2:167,380,115...167,384,734
|
|
G |
Snai2 |
snail family zinc finger 2 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [bisphenol A results in increased expression of SNAI2 protein]; 3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of SNAI2 protein]; 3,3'-diindolylmethane inhibits the reaction [Triclosan results in increased expression of SNAI2 protein] |
CTD |
PMID:28844962 |
|
NCBI chr16:14,523,716...14,527,259
Ensembl chr16:14,523,716...14,527,249
|
|
G |
Tff1 |
trefoil factor 1 |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [ESR1 protein binds to TFF1 promoter] |
CTD |
PMID:16972788 |
|
NCBI chr17:31,380,369...31,384,034
Ensembl chr17:31,380,369...31,384,251
|
|
G |
Tgfbr1 |
transforming growth factor, beta receptor I |
affects methylation |
ISO |
3,3'-diindolylmethane affects the methylation of TGFBR1 promoter |
CTD |
PMID:24466240 |
|
NCBI chr 4:47,353,258...47,414,926
Ensembl chr 4:47,353,222...47,414,931
|
|
G |
Timp1 |
tissue inhibitor of metalloproteinase 1 |
increases expression |
ISO |
3,3'-diindolylmethane analog results in increased expression of TIMP1 protein |
CTD |
PMID:25794856 |
|
NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974
|
|
G |
Tmem121b |
transmembrane protein 121B |
multiple interactions increases expression |
ISO |
3,3'-diindolylmethane promotes the reaction [ESR2 protein binds to TMEM121B promoter]; ESR2 affects the reaction [3,3'-diindolylmethane results in increased expression of TMEM121B mRNA]; NCOA2 mutant form inhibits the reaction [3,3'-diindolylmethane results in increased expression of TMEM121B mRNA] |
CTD |
PMID:20160136 |
|
NCBI chr 6:120,465,900...120,470,907
Ensembl chr 6:120,465,900...120,470,768
|
|
G |
Tnf |
tumor necrosis factor |
decreases expression multiple interactions |
ISO EXP |
3,3'-diindolylmethane results in decreased expression of TNF mRNA 3,3'-diindolylmethane inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of TNF protein] 3,3'-diindolylmethane inhibits the reaction [enterotoxin B, staphylococcal results in increased secretion of TNF protein] |
CTD |
PMID:22514694 PMID:24200994 PMID:26251508 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of TNFRSF1A mRNA |
CTD |
PMID:22514694 |
|
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
|
|
G |
Tnfrsf25 |
tumor necrosis factor receptor superfamily, member 25 |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of TNFRSF25 mRNA |
CTD |
PMID:22514694 |
|
NCBI chr 4:152,199,985...152,204,568
Ensembl chr 4:152,200,391...152,204,576
|
|
G |
Tnfsf8 |
tumor necrosis factor (ligand) superfamily, member 8 |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of TNFSF8 mRNA |
CTD |
PMID:22514694 |
|
NCBI chr 4:63,749,439...63,779,745
Ensembl chr 4:63,749,545...63,779,584
|
|
G |
Traf4 |
TNF receptor associated factor 4 |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of TRAF4 mRNA |
CTD |
PMID:22514694 |
|
NCBI chr11:78,049,249...78,056,405
Ensembl chr11:78,049,325...78,056,415
|
|
G |
Trp53 |
transformation related protein 53 |
multiple interactions |
ISO |
3,3'-diindolylmethane results in increased expression of and results in increased phosphorylation of and results in increased activity of TP53 protein; [3,3'-diindolylmethane results in increased phosphorylation of and results in increased activity of TP53 protein] which results in increased expression of BBC3; [3,3'-diindolylmethane results in increased phosphorylation of and results in increased activity of TP53 protein] which results in increased expression of PMAIP1; Wortmannin inhibits the reaction [3,3'-diindolylmethane results in increased phosphorylation of TP53 protein] |
CTD |
PMID:22290291 |
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Tyms |
thymidylate synthase |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of TYMS mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 5:30,243,544...30,279,261
Ensembl chr 5:30,263,200...30,278,615
|
|
G |
Ubb |
ubiquitin B |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Estradiol results in increased expression of UBB mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr11:62,442,329...62,444,037
Ensembl chr11:62,441,997...62,444,039
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of XIAP protein |
CTD |
PMID:22290291 |
|
NCBI chr X:41,148,483...41,198,541
Ensembl chr X:41,148,556...41,198,533
|
|
G |
Xrcc6 |
X-ray repair complementing defective repair in Chinese hamster cells 6 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of XRCC6 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr15:81,868,805...81,924,286
Ensembl chr15:81,872,036...81,924,286
|
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
ISO |
5-hydroxymethylomeprazole results in increased expression of CYP1A1 protein |
CTD |
PMID:10103034 |
|
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Cyp2c37 |
cytochrome P450, family 2. subfamily c, polypeptide 37 |
multiple interactions |
EXP |
[CYP2C37 protein results in increased metabolism of Omeprazole] which results in increased chemical synthesis of 5-hydroxymethylomeprazole |
CTD |
PMID:30503582 |
|
NCBI chr19:39,980,868...40,000,687
Ensembl chr19:39,980,868...40,000,687
|
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif 1 |
multiple interactions |
ISO |
[alpha-naphthoflavone co-treated with Methylcholanthrene] results in decreased acetylation of ADAMTS1 promoter; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased acetylation of ADAMTS1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased expression of ADAMTS1 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of ADAMTS1 promoter] |
CTD |
PMID:29094188 |
|
NCBI chr16:85,590,715...85,600,001
Ensembl chr16:85,590,715...85,600,001
|
|
G |
Ahr |
aryl-hydrocarbon receptor |
affects binding decreases activity multiple interactions |
ISO EXP |
[alpha-naphthoflavone binds to AHR protein] which binds to ESR1 protein; [alpha-naphthoflavone binds to AHR protein] which binds to ESRRA protein; [alpha-naphthoflavone binds to AHR protein] which binds to NR2F1 protein; alpha-naphthoflavone binds to AHR protein alpha-naphthoflavone results in decreased activity of AHR protein [alpha-naphthoflavone results in decreased activity of AHR protein] which results in decreased expression of CYP1A1 mRNA; AHR gene mutant form inhibits the reaction [alpha-naphthoflavone results in increased expression of IGFBP4 protein]; AHR protein promotes the reaction [alpha-naphthoflavone results in decreased expression of CDH13 mRNA]; alpha-naphthoflavone binds to and results in decreased activity of AHR protein; alpha-naphthoflavone binds to and results in increased activity of AHR protein; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [hydroquinone results in increased expression of AHR protein]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to BAX promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to CASP9 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to CDK2 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to DNAJB6 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to HES1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to ICAM1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to IGF2 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to JAG1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to SP1 promoter]]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased localization of and results in increased activity of AHR protein]; alpha-naphthoflavone promotes the reaction [beta-Naphthoflavone results in decreased expression of AHR mRNA] [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of IL10 protein]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] results in decreased susceptibility to [SB 203580 results in increased expression of CYP1A1]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to Benzo(a)pyrene; alpha-naphthoflavone binds to and results in decreased activity of AHR protein; alpha-naphthoflavone binds to and results in increased activity of AHR protein; alpha-naphthoflavone inhibits the reaction [AHR protein promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased localization of and results in increased activity of AHR protein] [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of and results in increased activity of MAPK1 protein]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of and results in increased activity of MAPK3 protein]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of and results in increased activity of STAT5B protein]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Skatole results in increased expression of CYP1A1 mRNA]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Skatole results in increased expression of CYP2F1 mRNA]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FLG mRNA]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to Hexachlorobenzene; [alpha-naphthoflavone results in decreased activity of AHR protein] inhibits the reaction [Tetrachlorodibenzodioxin results in increased abundance of Reactive Oxygen Species]; alpha-naphthoflavone analog inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; alpha-naphthoflavone analog results in increased activity of [AHR protein binds to ARNT protein]; alpha-naphthoflavone binds to and results in decreased activity of AHR protein; alpha-naphthoflavone inhibits the reaction [[AHR protein binds to ARNT protein] which binds to CYP1A1 enhancer]; alpha-naphthoflavone inhibits the reaction [[AHR protein binds to ARNT protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[Benzo(a)pyrene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[benzo(k)fluoranthene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[chrysene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[Oxygen deficiency co-treated with Tetrachlorodibenzodioxin] results in decreased stability of AHR protein]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased activity of BRCA1 protein]; alpha-naphthoflavone inhibits the reaction [AHR promotes the reaction [Tetrachlorodibenzodioxin results in decreased uptake of Glucose]]; alpha-naphthoflavone inhibits the reaction [AHR protein binds to and results in increased metabolism of Benzo(a)pyrene]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased activity of AHR protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of AHR protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of AHR protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of AHR protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased localization of and results in increased activity of AHR protein]; alpha-naphthoflavone results in increased activity of [AHR protein binds to ARNT protein] |
CTD |
PMID:1329656 PMID:7669069 PMID:8390116 PMID:8738555 PMID:9006915 PMID:10593590 PMID:10620335 PMID:11165043 PMID:11516172 PMID:11577022 PMID:11768231 PMID:12051995 PMID:12093619 PMID:12111005 PMID:12559965 PMID:12644593 PMID:12799773 PMID:14993811 PMID:15019843 PMID:15041469 PMID:15364539 PMID:15459018 PMID:15797623 PMID:16054781 PMID:16359657 PMID:17669606 PMID:17681673 PMID:18072750 PMID:18259752 PMID:19828881 PMID:20187624 PMID:20634293 PMID:21127131 PMID:21205633 PMID:21732638 PMID:21835898 PMID:22975028 PMID:23639626 PMID:24161567 PMID:26519956 PMID:29094188 PMID:29935983 More...
|
|
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
multiple interactions increases methylation |
ISO |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased acetylation of AKT1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of AKT1 mRNA] alpha-naphthoflavone results in increased methylation of AKT1 promoter |
CTD |
PMID:29094188 |
|
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Ar |
androgen receptor |
multiple interactions increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in decreased expression of AR protein]; alpha-naphthoflavone inhibits the reaction [Particulate Matter analog inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]]; alpha-naphthoflavone inhibits the reaction [Vehicle Emissions analog inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]]; bicalutamide inhibits the reaction [alpha-naphthoflavone inhibits the reaction [Particulate Matter analog inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]]]; bicalutamide inhibits the reaction [alpha-naphthoflavone inhibits the reaction [Vehicle Emissions analog inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]]] alpha-naphthoflavone results in increased expression of AR protein |
CTD |
PMID:12970580 PMID:15041469 |
|
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions |
ISO EXP |
alpha-naphthoflavone analog results in increased activity of [AHR protein binds to ARNT protein]; alpha-naphthoflavone inhibits the reaction [[AHR protein binds to ARNT protein] which binds to CYP1A1 enhancer]; alpha-naphthoflavone inhibits the reaction [[AHR protein binds to ARNT protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone results in increased activity of [AHR protein binds to ARNT protein] ARNT protein affects the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein] |
CTD |
PMID:11768231 PMID:21127131 PMID:30508555 |
|
NCBI chr 3:95,341,674...95,404,551
Ensembl chr 3:95,341,699...95,404,551
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BAX mRNA] alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to BAX promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of BAX mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of BAX promoter] |
CTD |
PMID:20562217 PMID:29094188 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bmp15 |
bone morphogenetic protein 15 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with alpha-naphthoflavone] results in increased expression of BMP15 mRNA |
CTD |
PMID:29094188 |
|
NCBI chr X:6,226,108...6,232,778
Ensembl chr X:6,226,161...6,232,775
|
|
G |
Bpgm |
2,3-bisphosphoglycerate mutase |
multiple interactions increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of BPGM mRNA] alpha-naphthoflavone results in increased expression of BPGM mRNA |
CTD |
PMID:23152189 |
|
NCBI chr 6:34,453,291...34,482,071
Ensembl chr 6:34,453,142...34,482,548
|
|
G |
Brca1 |
breast cancer 1, early onset |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased activity of BRCA1 protein]; alpha-naphthoflavone inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] |
CTD |
PMID:16489025 PMID:18259752 |
|
NCBI chr11:101,379,587...101,442,808
Ensembl chr11:101,379,590...101,442,781
|
|
G |
Calr |
calreticulin |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CALR mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr 8:85,568,717...85,573,560
Ensembl chr 8:85,568,479...85,573,563
|
|
G |
Casp12 |
caspase 12 |
increases cleavage |
EXP |
alpha-naphthoflavone results in increased cleavage of CASP12 protein |
CTD |
PMID:30508555 |
|
NCBI chr 9:5,345,419...5,373,034
Ensembl chr 9:5,345,430...5,373,032
|
|
G |
Casp3 |
caspase 3 |
increases activity multiple interactions increases cleavage decreases activity |
EXP ISO |
alpha-naphthoflavone results in increased activity of CASP3 protein alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased cleavage of CASP3 protein] alpha-naphthoflavone results in increased cleavage of CASP3 protein alpha-naphthoflavone results in decreased activity of CASP3 protein |
CTD |
PMID:15710172 PMID:18334599 PMID:30508555 PMID:35908932 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp8 |
caspase 8 |
increases activity |
EXP |
alpha-naphthoflavone results in increased activity of CASP8 protein |
CTD |
PMID:18334599 |
|
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Casp9 |
caspase 9 |
increases activity multiple interactions |
EXP ISO |
alpha-naphthoflavone results in increased activity of CASP9 protein [alpha-naphthoflavone co-treated with Methylcholanthrene] results in decreased acetylation of CASP9 promoter; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to CASP9 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CASP9 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of CASP9 promoter] |
CTD |
PMID:18334599 PMID:29094188 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in decreased activity of CAT protein] |
CTD |
PMID:20600218 |
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Ccl1 |
C-C motif chemokine ligand 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of CCL1] |
CTD |
PMID:16679317 |
|
NCBI chr11:82,067,492...82,070,638
Ensembl chr11:82,067,483...82,196,516
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression increases expression multiple interactions |
ISO |
alpha-naphthoflavone results in decreased expression of CCL2 mRNA alpha-naphthoflavone results in increased expression of CCL2 mRNA alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA] |
CTD |
PMID:22262711 |
|
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Plant Extracts results in decreased expression of CCNB1 mRNA] |
CTD |
PMID:25051199 |
|
NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in increased expression of CCND1 mRNA]; alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in increased expression of CCND1 protein] |
CTD |
PMID:31364906 |
|
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
|
|
G |
Cd9 |
CD9 antigen |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased expression of CD9 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr 6:125,437,229...125,471,723
Ensembl chr 6:125,437,229...125,471,754
|
|
G |
Cdc25c |
cell division cycle 25C |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Plant Extracts results in decreased expression of CDC25C mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of CDC25C protein] |
CTD |
PMID:22266097 PMID:25051199 |
|
NCBI chr18:34,866,046...34,884,644
Ensembl chr18:34,866,046...34,884,586
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in decreased expression of CDH1 mRNA]; alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in decreased expression of CDH1 protein] |
CTD |
PMID:31364906 |
|
NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
|
|
G |
Cdh13 |
cadherin 13 |
multiple interactions |
ISO |
AHR protein promotes the reaction [alpha-naphthoflavone results in decreased expression of CDH13 mRNA]; alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDH13 mRNA]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in decreased expression of CDH13 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDH13 mRNA] |
CTD |
PMID:12559965 |
|
NCBI chr 8:119,010,150...120,051,668
Ensembl chr 8:119,010,472...120,051,660
|
|
G |
Cdk1 |
cyclin dependent kinase 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of CDK1 protein] |
CTD |
PMID:22266097 |
|
NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases methylation multiple interactions |
ISO |
alpha-naphthoflavone results in decreased methylation of CDK2 promoter alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to CDK2 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased methylation of CDK2 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of CDK2 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CDK2 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr10:128,533,807...128,540,920
Ensembl chr10:128,533,808...128,540,900
|
|
G |
Cdkn1a |
cyclin dependent kinase inhibitor 1A |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene promotes the reaction [eupatorin-5-methyl ether results in increased expression of CDKN1A protein]]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of CDKN1A mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDKN1A protein] |
CTD |
PMID:21887816 PMID:22266097 PMID:23994263 PMID:24361490 |
|
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
|
|
G |
Cdkn1b |
cyclin dependent kinase inhibitor 1B |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDKN1B protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein] |
CTD |
PMID:15157999 PMID:22266097 |
|
NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
|
|
G |
Cebpd |
CCAAT/enhancer binding protein delta |
multiple interactions |
ISO |
alpha-naphthoflavone promotes the reaction [Particulate Matter results in increased expression of CEBPD mRNA] |
CTD |
PMID:21652769 |
|
NCBI chr16:15,705,150...15,707,409
Ensembl chr16:15,705,150...15,708,895
|
|
G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of CSF2 mRNA] |
CTD |
PMID:20801209 |
|
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
|
|
G |
Ctsd |
cathepsin D |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD mRNA]] |
CTD |
PMID:11165043 |
|
NCBI chr 7:141,929,647...141,941,564
Ensembl chr 7:141,929,648...141,941,775
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
multiple interactions decreases expression increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CXCL8 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CXCL8 mRNA] alpha-naphthoflavone results in decreased expression of CXCL8 mRNA alpha-naphthoflavone results in increased expression of CXCL8 mRNA |
CTD |
PMID:22262711 |
|
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Cygb |
cytoglobin |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole results in increased expression of CYGB mRNA] |
CTD |
PMID:25781201 |
|
NCBI chr11:116,536,421...116,544,887
Ensembl chr11:116,536,421...116,545,139
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases expression |
ISO |
alpha-naphthoflavone results in decreased expression of CYP17A1 mRNA |
CTD |
PMID:24875446 |
|
NCBI chr19:46,655,604...46,661,439
Ensembl chr19:46,655,604...46,661,611
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
multiple interactions increases expression |
ISO |
[alpha-naphthoflavone results in decreased activity of CYP19A1 protein] which results in decreased susceptibility to o,p'-DDT; alpha-naphthoflavone binds to and results in decreased activity of CYP19A1 protein; alpha-naphthoflavone inhibits the reaction [Aflatoxin B1 results in increased expression of CYP19A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CYP19A1 protein] alpha-naphthoflavone results in increased expression of CYP19A1 protein |
CTD |
PMID:9435150 PMID:20678559 PMID:20823264 PMID:21296134 |
|
NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases activity affects binding increases expression multiple interactions decreases activity |
ISO EXP |
alpha-naphthoflavone results in increased activity of CYP1A1 protein CYP1A1 protein binds to alpha-naphthoflavone alpha-naphthoflavone results in increased expression of CYP1A1 mRNA alpha-naphthoflavone analog results in increased expression of CYP1A1 mRNA; alpha-naphthoflavone results in increased expression of CYP1A1 mRNA; alpha-naphthoflavone results in increased expression of CYP1A1 protein [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Skatole results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [[3,4,5,3',4'-pentachlorobiphenyl co-treated with Benzo(a)pyrene] results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [[AHR protein binds to ARNT protein] which binds to CYP1A1 enhancer]; alpha-naphthoflavone inhibits the reaction [[AHR protein binds to ARNT protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[Benzo(a)pyrene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[benzo(k)fluoranthene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[chrysene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] which results in increased metabolism of Benzo(a)pyrene]; alpha-naphthoflavone inhibits the reaction [afimoxifene results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Calcitriol promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]]; alpha-naphthoflavone inhibits the reaction [Carbaryl results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Cycloheximide results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Resveratrol results in increased expression of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [STO 609 results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [Vehicle Emissions results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA] alpha-naphthoflavone results in decreased activity of CYP1A1 protein [alpha-naphthoflavone results in decreased activity of AHR protein] which results in decreased expression of CYP1A1 mRNA; [alpha-naphthoflavone results in decreased activity of CYP1A1 protein] inhibits the reaction [Vinyl Compounds analog results in decreased susceptibility to sodium arsenite]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of CYP1A1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of CYP1A1 promoter]; alpha-naphthoflavone inhibits the reaction [norisoboldine results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein]; alpha-naphthoflavone promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA] [[alpha-naphthoflavone results in decreased activity of CYP1A2 protein] co-treated with [alpha-naphthoflavone results in decreased activity of CYP1A1 protein]] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] results in decreased susceptibility to [SB 203580 results in increased expression of CYP1A1]; alpha-naphthoflavone inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; SRC protein affects the reaction [alpha-naphthoflavone results in increased expression of CYP1A1 mRNA]; SU 6656 inhibits the reaction [alpha-naphthoflavone results in increased expression of CYP1A1 mRNA] alpha-naphthoflavone analog results in increased activity of CYP1A1 protein |
CTD |
PMID:1329656 PMID:6477826 PMID:7669069 PMID:8390116 PMID:8637871 PMID:9169082 PMID:10496962 PMID:11339718 PMID:11516172 PMID:11768231 PMID:12051995 PMID:12093619 PMID:12111005 PMID:12799773 PMID:12859983 PMID:14993811 PMID:15075337 PMID:15276085 PMID:15306208 PMID:15385644 PMID:15456928 PMID:15698582 PMID:15766918 PMID:15893423 PMID:16426572 PMID:16906435 PMID:17069994 PMID:17275222 PMID:17872374 PMID:18308446 PMID:18493746 PMID:18755850 PMID:19244278 PMID:19553035 PMID:19828881 PMID:19901195 PMID:20187624 PMID:20801209 PMID:20816883 PMID:20823264 PMID:21053930 PMID:21127131 PMID:21162728 PMID:21621526 PMID:21652769 PMID:21732638 PMID:21932800 PMID:22837390 PMID:22975028 PMID:23099484 PMID:24161567 PMID:24361490 PMID:26221077 PMID:27163632 PMID:27393915 PMID:27966929 PMID:29094188 PMID:29274324 PMID:30508555 More...
|
|
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions affects binding increases expression increases metabolic processing affects metabolic processing decreases activity |
ISO EXP |
[alpha-naphthoflavone results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin; alpha-naphthoflavone binds to and results in decreased activity of CYP1A2 protein; alpha-naphthoflavone inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 mRNA]; alpha-naphthoflavone inhibits the reaction [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 mRNA]; alpha-naphthoflavone inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CYP1A2 protein binds to alpha-naphthoflavone alpha-naphthoflavone results in increased expression of CYP1A2 protein [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline co-treated with alpha-naphthoflavone] results in increased expression of CYP1A2 protein; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CYP1A2 protein results in increased metabolism of alpha-naphthoflavone [[alpha-naphthoflavone results in decreased activity of CYP1A2 protein] co-treated with [alpha-naphthoflavone results in decreased activity of CYP1A1 protein]] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]]; [alpha-naphthoflavone results in decreased activity of CYP1A2 protein] which results in decreased reduction of and results in decreased oxidation of 9-anthraldehyde alpha-naphthoflavone results in increased expression of CYP1A2 mRNA; alpha-naphthoflavone results in increased expression of CYP1A2 protein CYP1A2 protein affects the metabolism of alpha-naphthoflavone |
CTD |
PMID:2180560 PMID:9305587 PMID:15306208 PMID:15766918 PMID:15860655 PMID:17702393 PMID:18493746 PMID:19828881 PMID:20448087 PMID:20816883 PMID:21053930 PMID:21766881 PMID:21932800 PMID:26599973 PMID:27966929 PMID:28887089 PMID:29074051 PMID:33253783 PMID:33438235 More...
|
|
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions affects binding increases metabolic processing increases expression decreases expression decreases activity |
ISO EXP |
alpha-naphthoflavone binds to and results in decreased activity of CYP1B1 protein; alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1B1 mRNA]; alpha-naphthoflavone inhibits the reaction [6-formylindolo(3,2-b)carbazole results in increased expression of CYP1B1 mRNA]; alpha-naphthoflavone inhibits the reaction [[CYP1B1 protein co-treated with NADP] results in increased metabolism of 2,4,3',5'-tetramethoxystilbene]; alpha-naphthoflavone inhibits the reaction [[CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form]; alpha-naphthoflavone inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] CYP1B1 protein binds to alpha-naphthoflavone alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CYP1B1 mRNA] CYP1B1 protein results in increased metabolism of alpha-naphthoflavone alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1B1 protein]; alpha-naphthoflavone inhibits the reaction [AHR protein promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]] alpha-naphthoflavone results in increased expression of CYP1B1 mRNA alpha-naphthoflavone results in decreased expression of CYP1B1 mRNA alpha-naphthoflavone results in decreased activity of CYP1B1 protein |
CTD |
PMID:11577022 PMID:15075337 PMID:15280921 PMID:16120791 PMID:19182260 PMID:19563207 PMID:20823264 PMID:21053930 PMID:22262711 PMID:27163632 PMID:27966929 PMID:29146461 PMID:32553695 PMID:35908932 More...
|
|
NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to CYP24A1 promoter]]]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]]; alpha-naphthoflavone inhibits the reaction [Cycloheximide promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]] |
CTD |
PMID:19244278 |
|
NCBI chr 2:170,324,877...170,339,065
Ensembl chr 2:170,324,628...170,339,065
|
|
G |
Cyp2c52-ps |
cytochrome P450, family 2, subfamily c, polypeptide 52, pseudogene |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP2C11 mRNA] |
CTD |
PMID:18467041 |
|
NCBI chr19:38,965,106...38,992,071
Ensembl chr19:38,965,091...38,991,733
|
|
G |
Cyp2c65 |
cytochrome P450, family 2, subfamily c, polypeptide 65 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] |
CTD |
PMID:21053930 |
|
NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
|
|
G |
Cyp2f2 |
cytochrome P450, family 2, subfamily f, polypeptide 2 |
multiple interactions |
ISO |
[alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Skatole results in increased expression of CYP2F1 mRNA] |
CTD |
PMID:20187624 |
|
NCBI chr 7:26,819,380...26,833,085
Ensembl chr 7:26,819,334...26,833,085
|
|
G |
Cyp2j9 |
cytochrome P450, family 2, subfamily j, polypeptide 9 |
decreases activity |
ISO |
alpha-naphthoflavone results in decreased activity of CYP2J2 protein |
CTD |
PMID:12851038 |
|
NCBI chr 4:96,456,661...96,480,748
Ensembl chr 4:96,456,666...96,479,815
|
|
G |
Dazl |
deleted in azoospermia-like |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DAZL mRNA] |
CTD |
PMID:20562217 |
|
NCBI chr17:50,586,422...50,600,627
Ensembl chr17:50,586,423...50,600,664
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions increases expression |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; ARNT protein affects the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; pyrazolanthrone inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; salubrinal inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; SB 203580 inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; SRC protein affects the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; SU 6656 inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein] |
CTD |
PMID:30508555 |
|
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
|
|
G |
Ddr2 |
discoidin domain receptor family, member 2 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of DDR2 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr 1:169,799,874...169,938,525
Ensembl chr 1:169,799,876...169,938,331
|
|
G |
Ddx4 |
DEAD box helicase 4 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DDX4 mRNA] |
CTD |
PMID:20562217 |
|
NCBI chr13:112,734,867...112,790,342
Ensembl chr13:112,734,867...112,789,009
|
|
G |
Ddx5 |
DEAD box helicase 5 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of DDX5 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr11:106,671,181...106,680,011
Ensembl chr11:106,671,181...106,680,011
|
|
G |
Dll1 |
delta like canonical Notch ligand 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of DLL1 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr17:15,587,616...15,597,275
Ensembl chr17:15,587,616...15,597,134
|
|
G |
Dnajb6 |
DnaJ heat shock protein family (Hsp40) member B6 |
decreases methylation multiple interactions |
ISO |
alpha-naphthoflavone results in decreased methylation of DNAJB6 promoter alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to DNAJB6 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of DNAJB6 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of DNAJB6 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of DNAJB6 promoter] |
CTD |
PMID:29094188 |
|
NCBI chr 5:29,940,896...29,991,476
Ensembl chr 5:29,940,686...30,023,132
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of DUSP5 mRNA]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of DUSP5 protein] |
CTD |
PMID:19578757 |
|
NCBI chr19:53,517,576...53,530,240
Ensembl chr19:53,517,540...53,530,862
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of EGFR protein] |
CTD |
PMID:17934341 |
|
NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
|
|
G |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of EGLN1 mRNA]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of EGLN1 protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of EGLN1 mRNA] |
CTD |
PMID:18072750 |
|
NCBI chr 8:125,635,325...125,676,063
Ensembl chr 8:125,635,326...125,676,063
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
increases phosphorylation |
EXP |
alpha-naphthoflavone results in increased phosphorylation of EIF2S1 protein |
CTD |
PMID:30508555 |
|
NCBI chr12:78,908,846...78,933,784
Ensembl chr12:78,908,593...78,933,784
|
|
G |
Eno1 |
enolase 1, alpha non-neuron |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ENO1 mRNA] |
CTD |
PMID:23152189 |
|
NCBI chr 4:150,321,165...150,333,336
Ensembl chr 4:150,321,178...150,333,336 Ensembl chr18:150,321,178...150,333,336
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Oxygen deficiency inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of ENPP2 mRNA]]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of ENPP2 mRNA] |
CTD |
PMID:19028555 |
|
NCBI chr15:54,702,297...54,816,284
Ensembl chr15:54,702,297...54,816,288
|
|
G |
Esr1 |
estrogen receptor 1 (alpha) |
affects binding multiple interactions |
ISO |
[alpha-naphthoflavone binds to AHR protein] which binds to ESR1 protein alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [Estradiol binds to ESR1 protein]]; alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of ESR1 protein]; alpha-naphthoflavone inhibits the reaction [Particulate Matter analog inhibits the reaction [Estradiol binds to ESR1 protein]]; alpha-naphthoflavone inhibits the reaction [Vehicle Emissions analog inhibits the reaction [Estradiol binds to ESR1 protein]] [alpha-naphthoflavone co-treated with beta-Naphthoflavone] results in decreased expression of ESR1 mRNA; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased expression of ESR1 mRNA] |
CTD |
PMID:10620335 PMID:15253042 PMID:22975028 PMID:29094188 PMID:35181438 |
|
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
|
|
G |
Esr2 |
estrogen receptor 2 (beta) |
multiple interactions |
ISO |
[alpha-naphthoflavone co-treated with beta-Naphthoflavone] results in decreased expression of ESR2 mRNA |
CTD |
PMID:22975028 |
|
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
|
|
G |
Esrra |
estrogen related receptor, alpha |
affects binding |
ISO |
[alpha-naphthoflavone binds to AHR protein] which binds to ESRRA protein |
CTD |
PMID:10620335 |
|
NCBI chr19:6,888,345...6,899,182
Ensembl chr19:6,888,345...6,899,208
|
|
G |
Fas |
Fas cell surface death receptor |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FAS mRNA] |
CTD |
PMID:16940415 |
|
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
|
|
G |
Fasl |
Fas ligand |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FASL mRNA] |
CTD |
PMID:16940415 |
|
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein]]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein]] |
CTD |
PMID:20876236 |
|
NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257
|
|
G |
Flg |
filaggrin |
multiple interactions |
ISO |
[alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FLG mRNA] |
CTD |
PMID:21835898 |
|
NCBI chr 3:93,180,853...93,200,996
Ensembl chr 3:93,180,830...93,200,993
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of FOS mRNA]] |
CTD |
PMID:10478842 |
|
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
|
|
G |
Foxn3 |
forkhead box N3 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of FOXN3 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr12:99,156,340...99,529,926
Ensembl chr12:99,156,337...99,529,841
|
|
G |
Foxo3 |
forkhead box O3 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased phosphorylation of FOXO3 protein] [Methylcholanthrene co-treated with alpha-naphthoflavone] results in increased expression of FOXO3 mRNA |
CTD |
PMID:22266097 PMID:29094188 |
|
NCBI chr10:42,057,841...42,152,691
Ensembl chr10:42,057,837...42,152,751
|
|
G |
Foxp3 |
forkhead box P3 |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [tetrandrine results in increased expression of FOXP3 mRNA] |
CTD |
PMID:26640276 |
|
NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484
|
|
G |
Fshr |
follicle stimulating hormone receptor |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of FSHR protein] |
CTD |
PMID:20823264 |
|
NCBI chr17:89,292,380...89,508,103
Ensembl chr17:89,292,380...89,508,103
|
|
G |
Gdf9 |
growth differentiation factor 9 |
multiple interactions increases expression |
ISO |
[Methylcholanthrene co-treated with alpha-naphthoflavone] results in increased expression of GDF9 mRNA alpha-naphthoflavone results in increased expression of GDF9 mRNA |
CTD |
PMID:29094188 |
|
NCBI chr11:53,321,773...53,328,731
Ensembl chr11:53,321,850...53,328,731
|
|
G |
Gpi1 |
glucose-6-phosphate isomerase 1 |
multiple interactions increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of GPI mRNA] alpha-naphthoflavone results in increased expression of GPI mRNA |
CTD |
PMID:23152189 |
|
NCBI chr 7:33,900,752...33,929,761
Ensembl chr 7:33,900,755...33,929,761
|
|
G |
Gsr |
glutathione reductase |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of GSR mRNA] |
CTD |
PMID:23152189 |
|
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
|
|
G |
Gstp1 |
glutathione S-transferase, pi 1 |
decreases expression |
ISO |
alpha-naphthoflavone results in decreased expression of GSTP1 mRNA |
CTD |
PMID:18762178 |
|
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to HES1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of HES1 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr16:29,883,259...29,886,614
Ensembl chr16:29,883,202...29,886,614
|
|
G |
Hk1 |
hexokinase 1 |
multiple interactions increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of HK1 mRNA] alpha-naphthoflavone results in increased expression of HK1 mRNA |
CTD |
PMID:23152189 |
|
NCBI chr10:62,104,634...62,215,699
Ensembl chr10:62,104,634...62,215,687
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in decreased expression of HMGCR mRNA]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in decreased expression of HMGCR protein] |
CTD |
PMID:19931295 |
|
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
|
|
G |
Hspa8 |
heat shock protein 8 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of HSPA8 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of ICAM1 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to ICAM1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of ICAM1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of ICAM1 mRNA] |
CTD |
PMID:26519956 PMID:29094188 |
|
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Igf2 |
insulin-like growth factor 2 |
decreases acetylation multiple interactions |
ISO |
alpha-naphthoflavone results in decreased acetylation of IGF2 promoter alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to IGF2 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of IGF2 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of IGF2 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of IGF2 promoter] |
CTD |
PMID:29094188 |
|
NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553
|
|
G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
multiple interactions increases expression |
ISO |
AHR gene mutant form inhibits the reaction [alpha-naphthoflavone results in increased expression of IGFBP4 protein] |
CTD |
PMID:23639626 |
|
NCBI chr11:98,930,820...98,943,481
Ensembl chr11:98,932,070...98,945,218
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO EXP |
alpha-naphthoflavone inhibits the reaction [[Benzo(a)pyrene co-treated with Lipopolysaccharides] affects the expression of IL10 mRNA]; alpha-naphthoflavone inhibits the reaction [[Benzo(a)pyrene co-treated with Lipopolysaccharides] affects the expression of IL10 protein] [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of IL10 protein]; alpha-naphthoflavone inhibits the reaction [tetrandrine results in increased expression of IL10 mRNA] |
CTD |
PMID:11737050 PMID:17681673 PMID:26640276 |
|
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression decreases expression |
ISO EXP |
alpha-naphthoflavone analog inhibits the reaction [IL1B protein results in increased expression of SAA1 mRNA]; alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL1B mRNA]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of IL1B mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of IL1B mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IL1B mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IL1B protein] alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of IL1B mRNA] alpha-naphthoflavone results in increased expression of IL1B mRNA alpha-naphthoflavone results in decreased expression of IL1B mRNA |
CTD |
PMID:14993811 PMID:15019843 PMID:18617548 PMID:21127131 PMID:22262711 PMID:27393915 More...
|
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
multiple interactions increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL1RN mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IL1RN mRNA] alpha-naphthoflavone results in increased expression of IL1RN mRNA |
CTD |
PMID:22262711 |
|
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of IL6 mRNA]; alpha-naphthoflavone inhibits the reaction [Vehicle Emissions results in increased expression of IL6 mRNA] alpha-naphthoflavone inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of IL6 mRNA] alpha-naphthoflavone results in increased expression of IL6 mRNA |
CTD |
PMID:21162728 PMID:26519956 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Itgb8 |
integrin beta 8 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased expression of ITGB8 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr12:119,121,757...119,202,891
Ensembl chr12:119,121,757...119,202,537
|
|
G |
Jag1 |
jagged 1 |
decreases methylation multiple interactions |
ISO |
alpha-naphthoflavone results in decreased methylation of JAG1 promoter alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to JAG1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of JAG1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of JAG1 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of JAG1 promoter] |
CTD |
PMID:29094188 |
|
NCBI chr 2:136,923,371...136,958,440
Ensembl chr 2:136,923,376...136,958,564
|
|
G |
Jun |
jun proto-oncogene |
multiple interactions increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of JUN protein] alpha-naphthoflavone results in increased expression of JUN mRNA |
CTD |
PMID:15019843 PMID:15897893 |
|
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
|
|
G |
Krt14 |
keratin 14 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Plant Extracts results in decreased expression of KRT14 mRNA] |
CTD |
PMID:25051199 |
|
NCBI chr11:100,093,988...100,098,336
Ensembl chr11:100,093,988...100,098,374
|
|
G |
Ldha |
lactate dehydrogenase A |
multiple interactions increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of LDHA mRNA] alpha-naphthoflavone results in increased expression of LDHA mRNA |
CTD |
PMID:23152189 |
|
NCBI chr 7:46,491,698...46,505,051
Ensembl chr 7:46,490,899...46,505,051
|
|
G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of LHCGR protein] |
CTD |
PMID:20823264 |
|
NCBI chr17:89,023,812...89,099,487
Ensembl chr17:89,023,909...89,099,418
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions increases phosphorylation |
ISO EXP |
[alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of and results in increased activity of MAPK1 protein]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in increased phosphorylation of MAPK1 protein]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein]]; alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of MAPK1 protein] SU 6656 inhibits the reaction [alpha-naphthoflavone results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:19578757 PMID:20876236 PMID:21205633 PMID:26358519 PMID:30508555 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO EXP |
[alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of and results in increased activity of MAPK3 protein]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in increased phosphorylation of MAPK3 protein]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein]]; alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of MAPK3 protein] alpha-naphthoflavone results in increased phosphorylation of MAPK3 protein SU 6656 inhibits the reaction [alpha-naphthoflavone results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:19578757 PMID:20876236 PMID:21205633 PMID:26358519 PMID:30508555 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mdm2 |
transformed mouse 3T3 cell double minute 2 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [Oxygen deficiency results in increased expression of MDM2 mRNA]]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MDM2 mRNA] |
CTD |
PMID:19578757 |
|
NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663
|
|
G |
Mmp1b |
matrix metallopeptidase 1b (interstitial collagenase) |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MMP1 mRNA]; alpha-naphthoflavone inhibits the reaction [Tretinoin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of MMP1 mRNA]] alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP1 mRNA] |
CTD |
PMID:15075337 PMID:19022365 |
|
NCBI chr 9:7,367,670...7,388,026
Ensembl chr 9:7,368,239...7,388,047
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP2 mRNA] alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in increased expression of MMP2 mRNA]; alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in increased expression of MMP2 protein] |
CTD |
PMID:19022365 PMID:31364906 |
|
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP3 mRNA] |
CTD |
PMID:19022365 |
|
NCBI chr 9:7,445,845...7,455,975
Ensembl chr 9:7,445,822...7,455,975
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP9 mRNA] alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in increased expression of MMP9 mRNA]; alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in increased expression of MMP9 protein]; alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased secretion of and results in increased activity of MMP9 protein] |
CTD |
PMID:19022365 PMID:23462309 PMID:31364906 |
|
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
EXP |
alpha-naphthoflavone results in increased expression of MT1 mRNA |
CTD |
PMID:14998373 |
|
NCBI chr 8:94,905,214...94,906,955
Ensembl chr 8:94,905,710...94,906,955
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased phosphorylation of MTOR protein] |
CTD |
PMID:22266097 |
|
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
|
|
G |
Myc |
myelocytomatosis oncogene |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in decreased expression of MYC protein] alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in increased expression of MYC mRNA]; alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in increased expression of MYC protein] |
CTD |
PMID:22100782 PMID:31364906 |
|
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
|
|
G |
Myog |
myogenin |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in decreased expression of MYOG protein] |
CTD |
PMID:24431215 |
|
NCBI chr 1:134,217,742...134,220,286
Ensembl chr 1:134,217,727...134,220,286
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of NCF1 mRNA] |
CTD |
PMID:19559082 |
|
NCBI chr 5:134,248,907...134,258,479
Ensembl chr 5:134,248,907...134,258,479
|
|
G |
Ndufs1 |
NADH:ubiquinone oxidoreductase core subunit S1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of NDUFS1 mRNA] |
CTD |
PMID:23152189 |
|
NCBI chr 1:63,182,751...63,215,981
Ensembl chr 1:63,182,755...63,215,992
|
|
G |
Ndufs3 |
NADH:ubiquinone oxidoreductase core subunit S3 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of NDUFS3 mRNA] |
CTD |
PMID:23152189 |
|
NCBI chr 2:90,724,971...90,735,065
Ensembl chr 2:90,724,978...90,735,171
|
|
G |
Nfatc1 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of NFATC1 protein] |
CTD |
PMID:19028555 |
|
NCBI chr18:80,649,418...80,756,286
Ensembl chr18:80,649,420...80,756,286
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
multiple interactions increases expression |
ISO EXP |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of NOS2 protein] alpha-naphthoflavone results in increased expression of NOS2 protein |
CTD |
PMID:26086121 PMID:33722737 |
|
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Notch2 |
notch 2 |
increases methylation multiple interactions decreases acetylation |
ISO |
alpha-naphthoflavone results in increased methylation of NOTCH2 promoter alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased acetylation of NOTCH2 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of NOTCH2 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of NOTCH2 promoter] alpha-naphthoflavone results in decreased acetylation of NOTCH2 promoter |
CTD |
PMID:29094188 |
|
NCBI chr 3:97,920,854...98,057,683
Ensembl chr 3:97,920,843...98,057,677
|
|
G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
increases activity increases expression |
ISO |
alpha-naphthoflavone results in increased activity of NQO1 protein alpha-naphthoflavone results in increased expression of NQO1 mRNA |
CTD |
PMID:16906435 PMID:17069994 |
|
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases activity |
ISO |
alpha-naphthoflavone results in increased activity of NR1I3 protein |
CTD |
PMID:27732639 |
|
NCBI chr 1:171,041,503...171,046,414
Ensembl chr 1:171,041,539...171,048,270
|
|
G |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
affects binding |
ISO |
[alpha-naphthoflavone binds to AHR protein] which binds to NR2F1 protein |
CTD |
PMID:10620335 |
|
NCBI chr13:78,337,090...78,346,954
Ensembl chr13:78,337,092...78,347,876
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
increases cleavage |
EXP |
alpha-naphthoflavone results in increased cleavage of PARP1 protein |
CTD |
PMID:30508555 |
|
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
|
|
G |
Pfkm |
phosphofructokinase, muscle |
multiple interactions increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PFKM mRNA] alpha-naphthoflavone results in increased expression of PFKM mRNA |
CTD |
PMID:23152189 |
|
NCBI chr15:97,990,470...98,030,328
Ensembl chr15:97,990,470...98,030,332
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
multiple interactions increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PGK1 mRNA] alpha-naphthoflavone results in increased expression of PGK1 mRNA |
CTD |
PMID:23152189 |
|
NCBI chr X:105,230,706...105,247,305
Ensembl chr X:105,230,706...105,247,305
|
|
G |
Pgm1 |
phosphoglucomutase 1 |
increases expression multiple interactions |
ISO |
alpha-naphthoflavone results in increased expression of PGM1 mRNA alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PGM1 mRNA] |
CTD |
PMID:23152189 |
|
NCBI chr 4:99,786,648...99,844,491
Ensembl chr 4:99,786,611...99,844,491
|
|
G |
Pgr |
progesterone receptor |
increases expression |
ISO |
alpha-naphthoflavone results in increased expression of PGR protein |
CTD |
PMID:22266097 |
|
NCBI chr 9:8,890,017...8,968,612
Ensembl chr 9:8,899,834...8,968,612
|
|
G |
Pkm |
pyruvate kinase, muscle |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PKM mRNA] |
CTD |
PMID:23152189 |
|
NCBI chr 9:59,563,859...59,586,655
Ensembl chr 9:59,563,651...59,586,658
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [beta-Naphthoflavone results in increased expression of PPARA protein] |
CTD |
PMID:21849270 |
|
NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
|
|
G |
Prdm1 |
PR domain containing 1, with ZNF domain |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PRDM1 mRNA] |
CTD |
PMID:20562217 |
|
NCBI chr10:44,313,170...44,404,579
Ensembl chr10:44,313,173...44,404,497
|
|
G |
Prkcb |
protein kinase C, beta |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of PRKCB protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased localization of PRKCB protein] |
CTD |
PMID:16797713 PMID:17222441 |
|
NCBI chr 7:121,888,327...122,233,625
Ensembl chr 7:121,887,974...122,233,625
|
|
G |
Prl |
prolactin |
multiple interactions |
ISO |
alpha-naphthoflavone promotes the reaction [beta-Naphthoflavone results in decreased expression of PRL mRNA] |
CTD |
PMID:22975028 |
|
NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression multiple interactions increases expression |
ISO EXP |
alpha-naphthoflavone results in decreased expression of PTGS2 mRNA alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of PTGS2 mRNA] alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PTGS2 mRNA]; alpha-naphthoflavone inhibits the reaction [Chlorpyrifos results in increased expression of PTGS2 protein]; alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased expression of PTGS2 protein]; alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of PTGS2 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]; alpha-naphthoflavone inhibits the reaction [Vehicle Emissions results in increased expression of PTGS2 mRNA]; alpha-naphthoflavone promotes the reaction [Particulate Matter results in increased expression of PTGS2 mRNA] alpha-naphthoflavone results in increased expression of PTGS2 mRNA |
CTD |
PMID:21162728 PMID:21652769 PMID:22262711 PMID:26358519 PMID:27393915 PMID:32526215 More...
|
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Ptk2 |
PTK2 protein tyrosine kinase 2 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased phosphorylation of PTK2 protein] |
CTD |
PMID:16359657 |
|
NCBI chr15:73,076,951...73,297,192
Ensembl chr15:73,076,951...73,295,129
|
|
G |
Rack1 |
receptor for activated C kinase 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of RACK1 protein] |
CTD |
PMID:16797713 PMID:17222441 |
|
NCBI chr11:48,691,187...48,697,068
Ensembl chr11:48,691,159...48,697,261
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased phosphorylation of RB1 protein] |
CTD |
PMID:15157999 |
|
NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions decreases expression |
ISO EXP |
alpha-naphthoflavone inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased phosphorylation of RELA protein]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of RELA protein] alpha-naphthoflavone results in decreased expression of RELA protein |
CTD |
PMID:24431215 PMID:33722737 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Saa1 |
serum amyloid A 1 |
multiple interactions |
ISO |
alpha-naphthoflavone analog inhibits the reaction [IL1B protein results in increased expression of SAA1 mRNA] |
CTD |
PMID:21127131 |
|
NCBI chr 7:46,389,921...46,392,404
Ensembl chr 7:46,389,921...46,392,404
|
|
G |
Serpinb2 |
serine (or cysteine) peptidase inhibitor, clade B, member 2 |
multiple interactions decreases expression increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of SERPINB2 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of SERPINB2 mRNA]; alpha-naphthoflavone inhibits the reaction [Tretinoin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of SERPINB2 mRNA]] alpha-naphthoflavone results in decreased expression of SERPINB2 mRNA alpha-naphthoflavone results in increased expression of SERPINB2 mRNA |
CTD |
PMID:15075337 PMID:22262711 |
|
NCBI chr 1:107,439,153...107,453,330
Ensembl chr 1:107,439,153...107,463,208
|
|
G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
multiple interactions increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC2A1 mRNA] alpha-naphthoflavone results in increased expression of SLC2A1 mRNA |
CTD |
PMID:23152189 |
|
NCBI chr 4:118,966,001...118,994,527
Ensembl chr 4:118,965,908...118,995,180
|
|
G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in decreased expression of SLC5A5 protein] |
CTD |
PMID:26519956 |
|
NCBI chr 8:71,335,529...71,345,429
Ensembl chr 8:71,335,533...71,345,401
|
|
G |
Smad3 |
SMAD family member 3 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of SMAD3 protein] |
CTD |
PMID:27519288 |
|
NCBI chr 9:63,554,048...63,665,276
Ensembl chr 9:63,554,049...63,665,276
|
|
G |
Sp1 |
trans-acting transcription factor 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to SP1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of SP1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of SP1 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr15:102,314,751...102,344,839
Ensembl chr15:102,314,578...102,344,839
|
|
G |
Src |
Rous sarcoma oncogene |
multiple interactions increases phosphorylation |
EXP |
SRC protein affects the reaction [alpha-naphthoflavone results in increased expression of CYP1A1 mRNA]; SRC protein affects the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein] alpha-naphthoflavone results in increased phosphorylation of SRC protein |
CTD |
PMID:30508555 |
|
NCBI chr 2:157,265,828...157,313,758
Ensembl chr 2:157,260,364...157,313,782
|
|
G |
Stat5b |
signal transducer and activator of transcription 5B |
multiple interactions |
ISO |
[alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of and results in increased activity of STAT5B protein] |
CTD |
PMID:21205633 |
|
NCBI chr11:100,671,557...100,741,407
Ensembl chr11:100,671,557...100,741,550
|
|
G |
Synb |
syncytin b |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of ERVFRD-1 mRNA] |
CTD |
PMID:24361490 |
|
NCBI chr14:69,527,827...69,549,857
Ensembl chr14:69,526,793...69,531,748
|
|
G |
Tcf7 |
transcription factor 7, T cell specific |
increases expression |
ISO |
alpha-naphthoflavone results in increased expression of TCF7 mRNA |
CTD |
PMID:18762178 |
|
NCBI chr11:52,137,347...52,174,211
Ensembl chr11:52,143,198...52,174,158
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
alpha-naphthoflavone promotes the reaction [beta-Naphthoflavone results in decreased expression of TGFB1 mRNA] alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased expression of TGFB1 mRNA] |
CTD |
PMID:22975028 PMID:27519288 |
|
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
|
|
G |
Tiparp |
TCDD-inducible poly(ADP-ribose) polymerase |
decreases expression multiple interactions |
ISO |
alpha-naphthoflavone results in decreased expression of TIPARP mRNA alpha-naphthoflavone promotes the reaction [Particulate Matter results in increased expression of TIPARP mRNA] |
CTD |
PMID:18762178 PMID:21652769 |
|
NCBI chr 3:65,435,868...65,462,939
Ensembl chr 3:65,435,831...65,462,939
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP ISO |
alpha-naphthoflavone inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of TNF mRNA] alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of TNF mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of TNF mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased secretion of TNF protein] |
CTD |
PMID:17934341 PMID:20801209 PMID:23099484 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [hydroquinone results in increased expression of TNFRSF1A protein] |
CTD |
PMID:34200499 |
|
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
|
|
G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [hydroquinone results in increased expression of TNFRSF1B protein] |
CTD |
PMID:34200499 |
|
NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
|
|
G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [norisoboldine inhibits the reaction [TNFSF11 protein results in increased expression of VEGFA mRNA]] |
CTD |
PMID:26221077 |
|
NCBI chr14:78,514,886...78,545,483
Ensembl chr14:78,514,885...78,545,483
|
|
G |
Tpi1 |
triosephosphate isomerase 1 |
increases expression multiple interactions |
ISO |
alpha-naphthoflavone results in increased expression of TPI1 mRNA alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of TPI1 mRNA] |
CTD |
PMID:23152189 |
|
NCBI chr 6:124,787,549...124,791,121
Ensembl chr 6:124,787,549...124,791,259
|
|
G |
Trp53 |
transformation related protein 53 |
multiple interactions increases expression |
ISO EXP |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [leptomycin B results in increased expression of TP53 protein]] alpha-naphthoflavone inhibits the reaction [[CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form] alpha-naphthoflavone results in increased expression of TP53 protein alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased phosphorylation of TRP53 protein]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene affects the localization of TRP53 protein] |
CTD |
PMID:9006915 PMID:15459018 PMID:29274324 PMID:32553695 PMID:35908932 |
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Vdr |
vitamin D (1,25-dihydroxyvitamin D3) receptor |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to CYP24A1 promoter]]] |
CTD |
PMID:19244278 |
|
NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO EXP |
alpha-naphthoflavone affects the reaction [Hexachlorobenzene results in increased expression of VEGFA protein]; alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased secretion of VEGFA protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of VEGFA protein]; alpha-naphthoflavone promotes the reaction [Chlorpyrifos results in increased expression of VEGFA protein] alpha-naphthoflavone inhibits the reaction [norisoboldine results in decreased expression of VEGFA mRNA] alpha-naphthoflavone inhibits the reaction [norisoboldine inhibits the reaction [TNFSF11 protein results in increased expression of VEGFA mRNA]] |
CTD |
PMID:19182260 PMID:26221077 PMID:26358519 PMID:32526215 |
|
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
|
|
G |
Vim |
vimentin |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in increased expression of VIM mRNA]; alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in increased expression of VIM protein] |
CTD |
PMID:31364906 |
|
NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637
|
|
G |
Wapl |
WAPL cohesin release factor |
multiple interactions |
ISO |
alpha-naphthoflavone promotes the reaction [3-methylcholanthrylene results in increased expression of WAPL mRNA] |
CTD |
PMID:15797623 |
|
NCBI chr14:34,394,086...34,469,940
Ensembl chr14:34,395,885...34,469,940
|
|
|
G |
Abca1 |
ATP-binding cassette, sub-family A member 1 |
multiple interactions |
ISO |
amentoflavone inhibits the reaction [malondialdehyde-low density lipoprotein, human results in decreased expression of ABCA1 protein] |
CTD |
PMID:34599948 |
|
NCBI chr 4:53,030,789...53,159,988
Ensembl chr 4:53,030,787...53,159,895
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
multiple interactions |
EXP |
amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of AIF1 protein] |
CTD |
PMID:28185818 |
|
NCBI chr17:35,389,967...35,394,977
Ensembl chr17:35,389,967...35,395,044
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions |
EXP |
amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of BAX protein] |
CTD |
PMID:28185818 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions |
ISO EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]]; amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein] amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BCL2 protein] |
CTD |
PMID:28185818 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CASP3 protein modified form]]; amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CASP3 protein modified form] |
CTD |
PMID:28185818 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Cd36 |
CD36 molecule |
multiple interactions |
ISO |
amentoflavone inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased expression of CD36 mRNA]; amentoflavone inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased expression of CD36 protein]; CD36 protein inhibits the reaction [amentoflavone inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased expression of PPARG protein]] |
CTD |
PMID:34599948 |
|
NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
|
|
G |
Cdkn1a |
cyclin dependent kinase inhibitor 1A |
multiple interactions |
ISO |
amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CDKN1A protein] |
CTD |
PMID:28185818 |
|
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases activity |
ISO |
amentoflavone results in decreased activity of CYP1B1 protein |
CTD |
PMID:16271822 |
|
NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
|
|
G |
Dct |
dopachrome tautomerase |
decreases expression |
ISO |
amentoflavone analog results in decreased expression of DCT mRNA; amentoflavone analog results in decreased expression of DCT protein |
CTD |
PMID:17473463 |
|
NCBI chr14:118,250,202...118,289,658
Ensembl chr14:118,250,202...118,289,656
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
EXP |
amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of GFAP protein] |
CTD |
PMID:28185818 |
|
NCBI chr11:102,778,162...102,791,368
Ensembl chr11:102,778,162...102,791,738
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein] |
CTD |
PMID:28185818 |
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of MAPK1 protein]]; amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of MAPK1 protein] |
CTD |
PMID:28185818 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of MAPK3 protein]]; amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of MAPK3 protein] |
CTD |
PMID:28185818 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
decreases expression multiple interactions |
ISO EXP |
amentoflavone results in decreased expression of NOS2 protein amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of NOS2 protein] |
CTD |
PMID:12144868 PMID:28185818 |
|
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
multiple interactions |
ISO |
amentoflavone inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased expression of PPARG protein]; CD36 protein inhibits the reaction [amentoflavone inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased expression of PPARG protein]] |
CTD |
PMID:34599948 |
|
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
|
|
G |
Ptgds |
prostaglandin D2 synthase (brain) |
affects binding |
ISO |
amentoflavone binds to PTGDS protein |
CTD |
PMID:26456343 |
|
NCBI chr 2:25,356,723...25,360,080
Ensembl chr 2:25,356,721...25,360,058
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression multiple interactions |
ISO |
amentoflavone results in decreased expression of PTGS2 mRNA; amentoflavone results in decreased expression of PTGS2 protein [amentoflavone results in decreased expression of PTGS2 protein] which results in decreased chemical synthesis of Dinoprostone |
CTD |
PMID:12144868 |
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
decreases expression |
ISO |
amentoflavone results in decreased expression of SREBF1 mRNA |
CTD |
PMID:34599948 |
|
NCBI chr11:60,089,910...60,113,407
Ensembl chr11:60,089,915...60,113,407
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions |
EXP |
amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of TH mRNA]; amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of TH protein] |
CTD |
PMID:28185818 |
|
NCBI chr 7:142,446,516...142,453,732
Ensembl chr 7:142,446,489...142,484,865
|
|
G |
Tyr |
tyrosinase |
decreases activity |
ISO |
amentoflavone analog results in decreased activity of TYR protein |
CTD |
PMID:17473463 |
|
NCBI chr 7:87,073,979...87,142,637
Ensembl chr 7:87,073,979...87,142,720
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
decreases activity |
ISO |
amentoflavone results in decreased activity of UGT1A1 protein |
CTD |
PMID:29470958 |
|
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
|
|
G |
Ugt1a10 |
UDP glycosyltransferase 1 family, polypeptide A10 |
decreases activity |
ISO |
amentoflavone results in decreased activity of UGT1A10 protein |
CTD |
PMID:29470958 |
|
NCBI chr 1:87,983,133...88,147,724
Ensembl chr 1:87,983,110...88,146,726
|
|
G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
decreases activity |
ISO |
amentoflavone results in decreased activity of UGT1A3 protein |
CTD |
PMID:29470958 |
|
NCBI chr 1:88,128,333...88,147,724
Ensembl chr 1:88,128,323...88,146,719
|
|
G |
Ugt1a5 |
UDP glucuronosyltransferase 1 family, polypeptide A5 |
decreases activity |
ISO |
amentoflavone results in decreased activity of UGT1A4 protein |
CTD |
PMID:29470958 |
|
NCBI chr 1:88,093,734...88,147,724
Ensembl chr 1:88,093,734...88,146,719
|
|
G |
Ugt1a6b |
UDP glucuronosyltransferase 1 family, polypeptide A6B |
decreases activity multiple interactions |
ISO |
amentoflavone results in decreased activity of UGT1A6 protein amentoflavone inhibits the reaction [UGT1A6 protein results in increased glucuronidation of 4-cresol] |
CTD |
PMID:29470958 PMID:32421801 |
|
NCBI chr 1:88,030,979...88,146,720
Ensembl chr 1:88,030,974...88,146,725
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase 1 family, polypeptide A9 |
decreases activity |
ISO |
amentoflavone results in decreased activity of UGT1A9 protein |
CTD |
PMID:29470958 |
|
NCBI chr 1:87,998,501...88,147,724
Ensembl chr 1:87,998,522...88,146,719
|
|
G |
Ugt2b1 |
UDP glucuronosyltransferase 2 family, polypeptide B1 |
decreases activity |
ISO |
amentoflavone results in decreased activity of UGT2B17 protein |
CTD |
PMID:29470958 |
|
NCBI chr 5:87,064,498...87,074,362
Ensembl chr 5:87,064,497...87,074,389
|
|
|
G |
Acp1 |
acid phosphatase 1, soluble |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of ACP1 protein |
CTD |
PMID:26102013 |
|
NCBI chr12:30,943,325...30,961,616
Ensembl chr12:30,943,325...30,961,588
|
|
G |
Anp32b |
acidic nuclear phosphoprotein 32 family member B |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of ANP32B protein |
CTD |
PMID:26102013 |
|
NCBI chr 4:46,450,926...46,472,657
Ensembl chr 4:46,450,902...46,472,657
|
|
G |
Basp1 |
brain abundant, membrane attached signal protein 1 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of BASP1 protein |
CTD |
PMID:26102013 |
|
NCBI chr15:25,363,363...25,413,850
Ensembl chr15:25,363,363...25,413,850
|
|
G |
Bcap31 |
B cell receptor associated protein 31 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of BCAP31 protein |
CTD |
PMID:26102013 |
|
NCBI chr X:72,729,784...72,761,464
Ensembl chr X:72,729,784...72,759,781
|
|
G |
Cct4 |
chaperonin containing TCP1 subunit 4 |
increases expression |
ISO |
Aminoglutethimide results in increased expression of CCT4 protein |
CTD |
PMID:26102013 |
|
NCBI chr11:22,940,593...22,953,336
Ensembl chr11:22,940,519...22,953,780
|
|
G |
Cct6a |
chaperonin containing TCP1 subunit 6A |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of CCT6A protein |
CTD |
PMID:26102013 |
|
NCBI chr 5:129,864,420...129,875,284
Ensembl chr 5:129,864,062...129,875,212
|
|
G |
Cct7 |
chaperonin containing TCP1 subunit 7 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of CCT7 protein |
CTD |
PMID:26102013 |
|
NCBI chr 6:85,428,487...85,445,459
Ensembl chr 6:85,428,496...85,445,457
|
|
G |
Comt |
catechol-O-methyltransferase |
increases expression |
ISO |
Aminoglutethimide results in increased expression of COMT protein |
CTD |
PMID:26102013 |
|
NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602
|
|
G |
Cuta |
cutA divalent cation tolerance homolog |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of CUTA protein |
CTD |
PMID:26102013 |
|
NCBI chr17:27,156,946...27,158,847
Ensembl chr17:27,152,793...27,158,543
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
Aminoglutethimide inhibits the reaction [Colforsin results in increased expression of CYP11A1 mRNA] |
CTD |
PMID:16935330 |
|
NCBI chr 9:57,905,307...57,934,314
Ensembl chr 9:57,913,694...57,934,306
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of CYP17A1 mRNA |
CTD |
PMID:16935330 |
|
NCBI chr19:46,655,604...46,661,439
Ensembl chr19:46,655,604...46,661,611
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
multiple interactions increases activity decreases activity |
ISO |
Aminoglutethimide inhibits the reaction [Colforsin results in increased expression of CYP19A1 mRNA]; Aminoglutethimide inhibits the reaction [CYP19A1 protein affects the chemical synthesis of 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine]; Aminoglutethimide inhibits the reaction [CYP19A1 protein affects the metabolism of Methadone] Aminoglutethimide results in increased activity of CYP19A1 protein Aminoglutethimide results in decreased activity of CYP19A1 protein |
CTD |
PMID:15242824 PMID:15968818 PMID:16935330 PMID:17910019 PMID:20087668 |
|
NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394
|
|
G |
Fshb |
follicle stimulating hormone beta |
decreases expression multiple interactions |
ISO EXP |
Aminoglutethimide results in decreased expression of FSHB protein Aminoglutethimide inhibits the reaction [[FSHB protein co-treated with LHB protein co-treated with Testosterone] results in increased abundance of Acetaldehyde] |
CTD |
PMID:9208491 PMID:22285649 |
|
NCBI chr 2:106,886,331...106,889,996
Ensembl chr 2:106,886,485...106,890,001
|
|
G |
Gatd3a |
glutamine amidotransferase like class 1 domain containing 3A |
increases expression |
ISO |
Aminoglutethimide results in increased expression of GATD3 protein |
CTD |
PMID:26102013 |
|
NCBI chr10:77,997,900...78,005,589
Ensembl chr10:77,997,900...78,005,616
|
|
G |
Gns |
glucosamine (N-acetyl)-6-sulfatase |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of GNS protein |
CTD |
PMID:26102013 |
|
NCBI chr10:121,200,995...121,233,159
Ensembl chr10:121,200,995...121,233,154
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression |
ISO |
Aminoglutethimide results in increased expression of GPX1 protein |
CTD |
PMID:26102013 |
|
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
|
|
G |
Gsn |
gelsolin |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of GSN protein |
CTD |
PMID:26102013 |
|
NCBI chr 2:35,146,371...35,197,914
Ensembl chr 2:35,146,392...35,197,904
|
|
G |
H1f2 |
H1.2 linker histone, cluster member |
increases expression |
ISO |
Aminoglutethimide results in increased expression of H1-2 protein |
CTD |
PMID:26102013 |
|
NCBI chr13:23,922,790...23,923,514
Ensembl chr13:23,922,791...23,924,350
|
|
G |
H2ac12 |
H2A clustered histone 12 |
increases expression |
ISO |
Aminoglutethimide results in increased expression of H2AC12 protein |
CTD |
PMID:26102013 |
|
NCBI chr13:22,219,292...22,219,813
Ensembl chr13:22,219,334...22,219,738
|
|
G |
H2az1 |
H2A.Z variant histone 1 |
increases expression |
ISO |
Aminoglutethimide results in increased expression of H2AZ1 protein |
CTD |
PMID:26102013 |
|
NCBI chr 3:137,570,248...137,572,683
Ensembl chr 3:137,570,248...137,572,683
|
|
G |
H2bc12 |
H2B clustered histone 12 |
increases expression |
ISO |
Aminoglutethimide results in increased expression of H2BC12 protein |
CTD |
PMID:26102013 |
|
NCBI chr13:22,219,991...22,220,490
Ensembl chr13:22,220,040...22,220,515
|
|
G |
H3c11 |
H3 clustered histone 11 |
increases expression |
ISO |
Aminoglutethimide results in increased expression of H3C7 protein |
CTD |
PMID:26102013 |
|
NCBI chr13:21,967,085...21,967,567
Ensembl chr13:21,967,130...21,967,540
|
|
G |
H3c3 |
H3 clustered histone 3 |
increases expression |
ISO |
Aminoglutethimide results in increased expression of H3C13 protein |
CTD |
PMID:26102013 |
|
NCBI chr13:23,929,025...23,929,504
Ensembl chr13:23,928,956...23,929,585
|
|
G |
H4c12 |
H4 clustered histone 12 |
increases expression |
ISO |
Aminoglutethimide results in increased expression of H4C8 protein |
CTD |
PMID:26102013 |
|
NCBI chr13:21,934,315...21,934,723
Ensembl chr13:21,934,364...21,934,675
|
|
G |
Hmgb2 |
high mobility group box 2 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of HMGB2 protein |
CTD |
PMID:26102013 |
|
NCBI chr 8:57,964,877...57,969,033
Ensembl chr 8:57,964,941...57,969,033
|
|
G |
Hnrnph1 |
heterogeneous nuclear ribonucleoprotein H1 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of HNRNPH1 protein |
CTD |
PMID:26102013 |
|
NCBI chr11:50,266,084...50,277,355
Ensembl chr11:50,267,817...50,277,355
|
|
G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
multiple interactions |
ISO |
[Colforsin co-treated with Aminoglutethimide] results in decreased expression of HSD17B1 mRNA |
CTD |
PMID:16935330 |
|
NCBI chr11:100,968,792...100,972,014
Ensembl chr11:100,969,237...100,971,353
|
|
G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of HSD17B10 protein |
CTD |
PMID:26102013 |
|
NCBI chr X:150,784,892...150,787,438
Ensembl chr X:150,784,841...150,787,438
|
|
G |
Hsd17b4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
multiple interactions decreases expression |
ISO |
Aminoglutethimide inhibits the reaction [Colforsin results in increased expression of HSD17B4 mRNA] Aminoglutethimide results in decreased expression of HSD17B4 mRNA |
CTD |
PMID:16935330 |
|
NCBI chr18:50,261,268...50,329,337
Ensembl chr18:50,261,268...50,329,336
|
|
G |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of HSD17B7 mRNA |
CTD |
PMID:9231770 |
|
NCBI chr 1:169,777,109...169,796,757
Ensembl chr 1:169,777,104...169,796,810
|
|
G |
Hspa1a |
heat shock protein 1A |
increases expression |
ISO |
Aminoglutethimide results in increased expression of HSPA1A protein |
CTD |
PMID:26102013 |
|
NCBI chr17:35,188,335...35,191,132
Ensembl chr17:35,188,166...35,191,132
|
|
G |
Hyou1 |
hypoxia up-regulated 1 |
increases expression |
ISO |
Aminoglutethimide results in increased expression of HYOU1 protein |
CTD |
PMID:26102013 |
|
NCBI chr 9:44,290,840...44,303,662
Ensembl chr 9:44,290,787...44,303,666
|
|
G |
Impdh2 |
inosine monophosphate dehydrogenase 2 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of IMPDH2 protein |
CTD |
PMID:26102013 |
|
NCBI chr 9:108,437,635...108,442,776
Ensembl chr 9:108,437,485...108,442,783
|
|
G |
Lhb |
luteinizing hormone beta |
decreases expression multiple interactions |
ISO EXP |
Aminoglutethimide results in decreased expression of LHB protein Aminoglutethimide inhibits the reaction [[FSHB protein co-treated with LHB protein co-treated with Testosterone] results in increased abundance of Acetaldehyde] |
CTD |
PMID:9208491 PMID:22285649 |
|
NCBI chr 7:45,070,370...45,071,278
Ensembl chr 7:45,070,244...45,071,321
|
|
G |
Lmna |
lamin A |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of LMNA protein |
CTD |
PMID:26102013 |
|
NCBI chr 3:88,388,455...88,413,842
Ensembl chr 3:88,387,454...88,417,263
|
|
G |
Lmnb2 |
lamin B2 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of LMNB2 protein |
CTD |
PMID:26102013 |
|
NCBI chr10:80,737,197...80,754,079
Ensembl chr10:80,737,037...80,754,079
|
|
G |
Mcm3 |
minichromosome maintenance complex component 3 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of MCM3 protein |
CTD |
PMID:26102013 |
|
NCBI chr 1:20,873,188...20,890,536
Ensembl chr 1:20,873,192...20,890,536
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO |
[[MPO protein co-treated with Hydrogen Peroxide co-treated with 5,5-dimethyl-1-pyrroline-1-oxide] results in increased metabolism of Aminoglutethimide] which results in increased expression of MPO protein modified form; [Aminoglutethimide co-treated with Hydrogen Peroxide] results in increased oxidation of MPO protein; [MPO protein co-treated with Hydrogen Peroxide co-treated with 5,5-dimethyl-1-pyrroline-1-oxide] results in increased metabolism of Aminoglutethimide |
CTD |
PMID:20199096 PMID:26102013 |
|
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
|
|
G |
Myo18a |
myosin XVIIIA |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of MYO18A protein |
CTD |
PMID:26102013 |
|
NCBI chr11:77,654,066...77,756,806
Ensembl chr11:77,654,072...77,756,806
|
|
G |
Npm3 |
nucleoplasmin 3 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of NPM3 protein |
CTD |
PMID:26102013 |
|
NCBI chr19:45,736,173...45,738,004
Ensembl chr19:45,736,173...45,738,030
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity |
ISO |
Aminoglutethimide results in increased activity of NR1I2 protein |
CTD |
PMID:21068194 |
|
NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
|
|
G |
Nup210 |
nucleoporin 210 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of NUP210 protein |
CTD |
PMID:26102013 |
|
NCBI chr 6:90,990,049...91,095,920
Ensembl chr 6:90,990,050...91,093,811
|
|
G |
Pgr |
progesterone receptor |
multiple interactions decreases expression |
ISO |
[Aminoglutethimide co-treated with 17 alpha-Hydroxyprogesterone Caproate] results in decreased expression of PGR protein Aminoglutethimide results in decreased expression of PGR protein |
CTD |
PMID:8565696 PMID:9208491 |
|
NCBI chr 9:8,890,017...8,968,612
Ensembl chr 9:8,899,834...8,968,612
|
|
G |
Pitpnb |
phosphatidylinositol transfer protein, beta |
increases expression |
ISO |
Aminoglutethimide results in increased expression of PITPNB protein |
CTD |
PMID:26102013 |
|
NCBI chr 5:111,478,563...111,536,225
Ensembl chr 5:111,478,629...111,536,225
|
|
G |
Ppp1ca |
protein phosphatase 1 catalytic subunit alpha |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of PPP1CA protein |
CTD |
PMID:26102013 |
|
NCBI chr19:4,242,173...4,245,418
Ensembl chr19:4,242,064...4,245,419
|
|
G |
Prdx3 |
peroxiredoxin 3 |
increases expression |
ISO |
Aminoglutethimide results in increased expression of PRDX3 protein |
CTD |
PMID:26102013 |
|
NCBI chr19:60,852,504...60,862,976
Ensembl chr19:60,852,489...60,862,994
|
|
G |
Psmb4 |
proteasome (prosome, macropain) subunit, beta type 4 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of PSMB4 protein |
CTD |
PMID:26102013 |
|
NCBI chr 3:94,791,635...94,794,269
Ensembl chr 3:94,791,404...94,794,272
|
|
G |
Rtraf |
RNA transcription, translation and transport factor |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of RTRAF protein |
CTD |
PMID:26102013 |
|
NCBI chr14:19,861,470...19,873,891
Ensembl chr14:19,861,419...19,873,892
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of SPP1 mRNA |
CTD |
PMID:23558518 |
|
NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
|
|
G |
Ssb |
small RNA binding exonuclease protection factor La |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of SSB protein |
CTD |
PMID:26102013 |
|
NCBI chr 2:69,691,963...69,702,185
Ensembl chr 2:69,691,906...69,702,190
|
|
G |
Star |
steroidogenic acute regulatory protein |
decreases expression increases expression |
ISO EXP |
Aminoglutethimide results in decreased expression of STAR mRNA Aminoglutethimide results in increased expression of STAR mRNA |
CTD |
PMID:10960482 PMID:16935330 |
|
NCBI chr 8:26,298,502...26,306,010
Ensembl chr 8:26,296,583...26,306,010
|
|
G |
Tpt1 |
tumor protein, translationally-controlled 1 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of TPT1 protein |
CTD |
PMID:26102013 |
|
NCBI chr14:76,082,771...76,085,743
Ensembl chr14:76,082,533...76,085,965
|
|
G |
Ubc |
ubiquitin C |
increases expression |
ISO |
Aminoglutethimide results in increased expression of UBC protein |
CTD |
PMID:26102013 |
|
NCBI chr 5:125,463,029...125,467,081
Ensembl chr 5:125,463,029...125,467,266
|
|
G |
Ube2k |
ubiquitin-conjugating enzyme E2K |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of UBE2K protein |
CTD |
PMID:26102013 |
|
NCBI chr 5:65,694,588...65,756,332
Ensembl chr 5:65,694,576...65,756,331
|
|
G |
Wdr1 |
WD repeat domain 1 |
increases expression |
ISO |
Aminoglutethimide results in increased expression of WDR1 protein |
CTD |
PMID:26102013 |
|
NCBI chr 5:38,684,149...38,720,265
Ensembl chr 5:38,684,156...38,720,564
|
|
G |
Ywhaq |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta |
increases expression |
ISO |
Aminoglutethimide results in increased expression of YWHAQ protein |
CTD |
PMID:26102013 |
|
NCBI chr12:21,440,330...21,467,437
Ensembl chr12:21,440,072...21,467,638
|
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO |
[Oleic Acid co-treated with anastrozole] affects the localization of CYCS protein; [Olive Oil co-treated with anastrozole] affects the localization of CYCS protein |
CTD |
PMID:24161488 |
|
NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
decreases activity |
ISO |
Anastrozole results in decreased activity of CYP19A1 protein |
CTD |
PMID:15837728 PMID:16001952 PMID:16023338 PMID:16023854 PMID:16034487 PMID:16054421 PMID:21341743 PMID:32764486 More...
|
|
NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394
|
|
G |
Fshb |
follicle stimulating hormone beta |
increases expression |
ISO |
anastrozole results in increased expression of FSHB protein |
CTD |
PMID:10657858 |
|
NCBI chr 2:106,886,331...106,889,996
Ensembl chr 2:106,886,485...106,890,001
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
decreases expression |
ISO |
anastrozole results in decreased expression of GJA1 protein |
CTD |
PMID:29180066 |
|
NCBI chr10:56,253,297...56,266,519
Ensembl chr10:56,253,426...56,278,609
|
|
G |
Lhb |
luteinizing hormone beta |
increases expression |
ISO |
anastrozole results in increased expression of LHB protein |
CTD |
PMID:10657858 |
|
NCBI chr 7:45,070,370...45,071,278
Ensembl chr 7:45,070,244...45,071,321
|
|
G |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
multiple interactions decreases expression |
ISO |
[Tamoxifen co-treated with anastrozole] results in decreased expression of MKI67 protein anastrozole results in decreased expression of MKI67 protein |
CTD |
PMID:15767642 PMID:16002280 |
|
NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
|
|
G |
Pgr |
progesterone receptor |
decreases expression |
ISO |
anastrozole results in decreased expression of PGR protein |
CTD |
PMID:16002280 |
|
NCBI chr 9:8,890,017...8,968,612
Ensembl chr 9:8,899,834...8,968,612
|
|
G |
Por |
cytochrome p450 oxidoreductase |
decreases activity |
ISO |
Anastrozole results in decreased activity of POR protein |
CTD |
PMID:35206146 |
|
NCBI chr 5:135,698,894...135,764,180
Ensembl chr 5:135,698,887...135,764,180
|
|
G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
multiple interactions |
ISO |
anastrozole inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
|
|
|
G |
Aatf |
apoptosis antagonizing transcription factor |
decreases expression |
ISO |
beauvericin results in decreased expression of AATF mRNA |
CTD |
PMID:29203277 |
|
NCBI chr11:84,313,682...84,404,433
Ensembl chr11:84,313,681...84,404,348
|
|
G |
Abca1 |
ATP-binding cassette, sub-family A member 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ABCA1 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr 4:53,030,789...53,159,988
Ensembl chr 4:53,030,787...53,159,895
|
|
G |
Abcg1 |
ATP binding cassette subfamily G member 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ABCG1 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr17:31,276,668...31,336,958
Ensembl chr17:31,276,649...31,336,962
|
|
G |
Acat2 |
acetyl-Coenzyme A acetyltransferase 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ACAT2 protein |
CTD |
PMID:32407736 |
|
NCBI chr17:13,161,929...13,179,612
Ensembl chr17:13,161,777...13,179,634
|
|
G |
Acin1 |
apoptotic chromatin condensation inducer 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of ACIN1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr14:54,879,618...54,924,422
Ensembl chr14:54,879,618...54,924,388
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ACSL4 protein |
CTD |
PMID:32407736 |
|
NCBI chr X:141,100,989...141,173,792
Ensembl chr X:141,100,989...141,173,531
|
|
G |
Actb |
actin, beta |
decreases expression |
ISO |
beauvericin results in decreased expression of ACTB mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 5:142,888,870...142,892,509
Ensembl chr 5:142,888,870...142,892,509
|
|
G |
Aen |
apoptosis enhancing nuclease |
decreases expression |
ISO |
beauvericin results in decreased expression of AEN mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 7:78,545,675...78,560,957
Ensembl chr 7:78,545,602...78,560,957
|
|
G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of AIFM1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr X:47,563,821...47,602,440
Ensembl chr X:47,563,821...47,602,440
|
|
G |
Ak4 |
adenylate kinase 4 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of AK4 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr 4:101,273,675...101,324,968
Ensembl chr 4:101,276,474...101,324,192
|
|
G |
Aldh5a1 |
aldhehyde dehydrogenase family 5, subfamily A1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ALDH5A1 protein |
CTD |
PMID:32407736 |
|
NCBI chr13:25,091,562...25,121,740
Ensembl chr13:25,091,562...25,121,644 Ensembl chr13:25,091,562...25,121,644
|
|
G |
Anapc13 |
anaphase promoting complex subunit 13 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ANAPC13 protein |
CTD |
PMID:32407736 |
|
NCBI chr 9:102,503,495...102,511,443
Ensembl chr 9:102,503,495...102,511,624
|
|
G |
Aprt |
adenine phosphoribosyl transferase |
decreases expression |
ISO |
beauvericin results in decreased expression of APRT mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 8:123,301,376...123,303,646
Ensembl chr 8:123,301,374...123,303,648
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
beauvericin inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA] |
CTD |
PMID:30716354 |
|
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
|
|
G |
Arhgdia |
Rho GDP dissociation inhibitor alpha |
decreases expression |
ISO |
beauvericin results in decreased expression of ARHGDIA mRNA |
CTD |
PMID:29203277 |
|
NCBI chr11:120,468,925...120,472,450
Ensembl chr11:120,468,930...120,472,450
|
|
G |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
increases expression |
ISO |
beauvericin results in increased expression of ARPP21 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 9:111,894,159...112,065,356
Ensembl chr 9:111,894,159...112,065,006
|
|
G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of ATP1A1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 3:101,483,535...101,512,023
Ensembl chr 3:101,483,535...101,512,000
|
|
G |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ATP1A3 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:24,677,592...24,705,338
Ensembl chr 7:24,677,592...24,705,383
|
|
G |
Atp5pb |
ATP synthase peripheral stalk-membrane subunit b |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ATP5PB protein |
CTD |
PMID:32407736 |
|
NCBI chr 3:105,850,014...105,866,579
Ensembl chr 3:105,850,014...105,867,415
|
|
G |
Atp5pf |
ATP synthase peripheral stalk subunit F6 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ATP5PF protein |
CTD |
PMID:32407736 |
|
NCBI chr16:84,624,754...84,632,495
Ensembl chr16:84,624,754...84,632,513
|
|
G |
Bax |
BCL2-associated X protein |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of BAX mRNA [zearalenol co-treated with beauvericin] results in increased expression of BAX mRNA |
CTD |
PMID:29203277 PMID:32956828 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
increases expression multiple interactions |
ISO |
beauvericin results in increased expression of BCL2 mRNA [zearalenol co-treated with beauvericin] results in increased expression of BCL2 mRNA |
CTD |
PMID:29203277 PMID:32956828 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
increases expression |
ISO |
beauvericin results in increased expression of BIRC2 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 9:7,818,227...7,837,123
Ensembl chr 9:7,818,228...7,837,065
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
increases expression |
ISO |
beauvericin results in increased expression of BIRC3 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187
|
|
G |
Btf3l4 |
basic transcription factor 3-like 4 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of BTF3L4 protein |
CTD |
PMID:32407736 |
|
NCBI chr 4:108,671,489...108,691,445
Ensembl chr 4:108,671,492...108,690,811
|
|
G |
C1qtnf3 |
C1q and tumor necrosis factor related protein 3 |
decreases expression |
ISO |
beauvericin results in decreased expression of C1QTNF3 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr15:10,952,418...10,980,248
Ensembl chr15:10,952,418...10,980,236
|
|
G |
C1qtnf6 |
C1q and tumor necrosis factor related protein 6 |
increases expression |
ISO |
beauvericin results in increased expression of C1QTNF6 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr15:78,407,546...78,416,370
Ensembl chr15:78,407,546...78,415,616
|
|
G |
Caap1 |
caspase activity and apoptosis inhibitor 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of CAAP1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 4:94,388,318...94,445,033
Ensembl chr 4:94,388,318...94,445,033
|
|
G |
Card11 |
caspase recruitment domain family, member 11 |
decreases expression |
ISO |
beauvericin results in decreased expression of CARD11 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 5:140,858,109...140,986,398
Ensembl chr 5:140,858,745...140,986,337
|
|
G |
Casp3 |
caspase 3 |
increases activity multiple interactions |
ISO |
beauvericin results in increased activity of CASP3 protein [zearalenol co-treated with beauvericin] results in increased expression of CASP3 mRNA |
CTD |
PMID:25178661 PMID:32956828 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp7 |
caspase 7 |
increases activity |
ISO |
beauvericin results in increased activity of CASP7 protein |
CTD |
PMID:25178661 |
|
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
|
|
G |
Casp8 |
caspase 8 |
increases expression |
ISO |
beauvericin results in increased expression of CASP8 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Casp9 |
caspase 9 |
increases expression |
ISO |
beauvericin results in increased expression of CASP9 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Ccar2 |
cell cycle activator and apoptosis regulator 2 |
decreases expression |
ISO |
beauvericin results in decreased expression of CCAR2 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr14:70,375,617...70,391,272
Ensembl chr14:70,375,613...70,391,260
|
|
G |
Ccdc124 |
coiled-coil domain containing 124 |
decreases expression |
ISO |
beauvericin results in decreased expression of CCDC124 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 8:71,320,870...71,326,134
Ensembl chr 8:71,320,871...71,326,579
|
|
G |
Ccdc180 |
coiled-coil domain containing 180 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CCDC180 protein |
CTD |
PMID:32407736 |
|
NCBI chr 4:45,890,303...45,950,774
Ensembl chr 4:45,890,303...45,950,774
|
|
G |
Ccdc86 |
coiled-coil domain containing 86 |
decreases expression |
ISO |
beauvericin results in decreased expression of CCDC86 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr19:10,918,845...10,926,630
Ensembl chr19:10,918,845...10,926,630
|
|
G |
Ccng2 |
cyclin G2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CCNG2 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr 5:93,415,432...93,424,090
Ensembl chr 5:93,415,116...93,424,090
|
|
G |
Cct5 |
chaperonin containing TCP1 subunit 5 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of CCT5 protein |
CTD |
PMID:32407736 |
|
NCBI chr15:31,590,946...31,601,992
Ensembl chr15:31,590,946...31,601,950
|
|
G |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of CD47 protein |
CTD |
PMID:32407736 |
|
NCBI chr16:49,671,691...49,732,799
Ensembl chr16:49,620,896...49,735,373
|
|
G |
Cd81 |
CD81 antigen |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of CD81 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:142,606,487...142,621,667
Ensembl chr 7:142,606,476...142,621,671
|
|
G |
Cdk2ap2 |
cyclin dependent kinase 2 associated protein 2 |
decreases expression |
ISO |
beauvericin results in decreased expression of CDK2AP2 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr19:4,146,204...4,149,019
Ensembl chr19:4,147,182...4,149,019
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CEBPB mRNA |
CTD |
PMID:31100301 |
|
NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
increases expression |
ISO |
beauvericin results in increased expression of CFLAR mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:58,750,353...58,798,043
Ensembl chr 1:58,750,667...58,798,043
|
|
G |
Chchd2 |
coiled-coil-helix-coiled-coil-helix domain containing 2 |
decreases expression |
ISO |
beauvericin results in decreased expression of CHCHD2 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 5:129,910,002...129,916,311
Ensembl chr 5:129,909,997...129,916,311
|
|
G |
Ciapin1 |
cytokine induced apoptosis inhibitor 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of CIAPIN1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 8:95,546,446...95,565,454
Ensembl chr 8:95,546,432...95,564,986
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of CNP protein |
CTD |
PMID:32407736 |
|
NCBI chr11:100,465,765...100,472,565
Ensembl chr11:100,465,730...100,482,555
|
|
G |
Coa6 |
cytochrome c oxidase assembly factor 6 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of COA6 protein |
CTD |
PMID:32407736 |
|
NCBI chr 8:127,149,267...127,152,174
Ensembl chr 8:127,149,254...127,152,172
|
|
G |
Coro1c |
coronin, actin binding protein 1C |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of CORO1C protein |
CTD |
PMID:32407736 |
|
NCBI chr 5:113,980,500...114,046,767
Ensembl chr 5:113,980,497...114,046,819
|
|
G |
Cotl1 |
coactosin like F-actin binding protein 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of COTL1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 8:120,535,953...120,567,318
Ensembl chr 8:120,535,961...120,567,283
|
|
G |
Cplane2 |
ciliogenesis and planar polarity effector 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of CPLANE2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 4:140,941,249...140,947,425
Ensembl chr 4:140,941,267...140,954,067
|
|
G |
Cpne1 |
copine I |
decreases expression |
ISO |
beauvericin results in decreased expression of CPNE1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 2:155,913,765...155,953,847
Ensembl chr 2:155,913,762...155,953,885
|
|
G |
Crim1 |
cysteine rich transmembrane BMP regulator 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CRIM1 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr17:78,507,602...78,684,021
Ensembl chr17:78,507,677...78,684,021
|
|
G |
Csdc2 |
cold shock domain containing C2, RNA binding |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CSDC2 protein |
CTD |
PMID:32407736 |
|
NCBI chr15:81,820,960...81,835,142
Ensembl chr15:81,820,960...81,835,142
|
|
G |
Csk |
c-src tyrosine kinase |
decreases expression |
ISO |
beauvericin results in decreased expression of CSK mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 9:57,533,929...57,560,758
Ensembl chr 9:57,533,929...57,560,914
|
|
G |
Ctps1 |
cytidine 5'-triphosphate synthase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CTPS1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 4:120,397,065...120,427,473
Ensembl chr 4:120,397,065...120,427,473
|
|
G |
Ctsd |
cathepsin D |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CTSD protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:141,929,647...141,941,564
Ensembl chr 7:141,929,648...141,941,775
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CXCL8 protein |
CTD |
PMID:32407736 |
|
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Cyp4f39 |
cytochrome P450, family 4, subfamily f, polypeptide 39 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CYP4F22 protein |
CTD |
PMID:32407736 |
|
NCBI chr17:32,671,670...32,712,294
Ensembl chr17:32,671,697...32,712,294
|
|
G |
Dcxr |
dicarbonyl L-xylulose reductase |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of DCXR protein |
CTD |
PMID:32407736 |
|
NCBI chr11:120,615,372...120,618,110
Ensembl chr11:120,616,225...120,618,107
|
|
G |
Ddias |
DNA damage-induced apoptosis suppressor |
decreases expression |
ISO |
beauvericin results in decreased expression of DDIAS mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 7:92,506,734...92,523,455
Ensembl chr 7:92,506,733...92,523,455
|
|
G |
Ddx47 |
DEAD box helicase 47 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of DDX47 protein |
CTD |
PMID:32407736 |
|
NCBI chr 6:134,988,575...135,000,739
Ensembl chr 6:134,988,575...135,000,739
|
|
G |
Dhrs7 |
dehydrogenase/reductase 7 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of DHRS7 protein |
CTD |
PMID:32407736 |
|
NCBI chr12:72,697,127...72,711,678
Ensembl chr12:72,697,127...72,711,683
|
|
G |
Edem1 |
ER degradation enhancer, mannosidase alpha-like 1 |
increases expression |
ISO |
beauvericin results in increased expression of EDEM1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 6:108,800,984...108,836,317
Ensembl chr 6:108,805,602...108,836,317
|
|
G |
Eif5a |
eukaryotic translation initiation factor 5A |
decreases expression |
ISO |
beauvericin results in decreased expression of EIF5A mRNA |
CTD |
PMID:29203277 |
|
NCBI chr11:69,807,538...69,812,784
Ensembl chr11:69,807,540...69,812,784
|
|
G |
Faim2 |
Fas apoptotic inhibitory molecule 2 |
increases expression |
ISO |
beauvericin results in increased expression of FAIM2 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr15:99,394,886...99,432,757
Ensembl chr15:99,394,893...99,426,046
|
|
G |
Fmc1 |
formation of mitochondrial complex V assembly factor 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of FMC1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 6:38,511,796...38,516,384
Ensembl chr 6:38,510,437...38,516,384
|
|
G |
Gaa |
glucosidase, alpha, acid |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of GAA protein |
CTD |
PMID:32407736 |
|
NCBI chr11:119,158,789...119,176,284
Ensembl chr11:119,158,713...119,176,280
|
|
G |
Gna14 |
guanine nucleotide binding protein, alpha 14 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of GNA14 protein |
CTD |
PMID:32407736 |
|
NCBI chr19:16,413,031...16,590,706
Ensembl chr19:16,413,126...16,588,184
|
|
G |
Gnai3 |
G protein subunit alpha i3 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of GNAI3 protein |
CTD |
PMID:32407736 |
|
NCBI chr 3:108,014,591...108,053,468
Ensembl chr 3:108,014,596...108,053,462
|
|
G |
Gnb1 |
guanine nucleotide binding protein (G protein), beta 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of GNB1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 4:155,575,514...155,643,726
Ensembl chr 4:155,575,818...155,643,726
|
|
G |
Golga1 |
golgin A1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of GOLGA1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:38,906,167...38,955,568
Ensembl chr 2:38,906,167...38,955,553
|
|
G |
Gpnmb |
glycoprotein (transmembrane) nmb |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of GPNMB protein |
CTD |
PMID:32407736 |
|
NCBI chr 6:49,013,449...49,044,413
Ensembl chr 6:49,013,480...49,047,863
|
|
G |
Gpr18 |
G protein-coupled receptor 18 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of GPR18 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr14:122,148,846...122,153,300
Ensembl chr14:122,148,665...122,153,193
|
|
G |
H2bc21 |
H2B clustered histone 21 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of HIST2H2BE protein |
CTD |
PMID:32407736 |
|
NCBI chr 3:96,128,435...96,131,057
Ensembl chr 3:96,128,435...96,131,054
|
|
G |
Hexb |
hexosaminidase B |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of HEXB protein |
CTD |
PMID:32407736 |
|
NCBI chr13:97,312,839...97,334,865
Ensembl chr13:97,312,839...97,334,865
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of HMGCS1 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr13:120,151,887...120,169,796
Ensembl chr13:120,151,915...120,169,796
|
|
G |
Hnrnpm |
heterogeneous nuclear ribonucleoprotein M |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of HNRNPM protein |
CTD |
PMID:32407736 |
|
NCBI chr17:33,865,207...33,904,432
Ensembl chr17:33,865,207...33,905,834
|
|
G |
Hnrnpu |
heterogeneous nuclear ribonucleoprotein U |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of HNRNPU protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:178,148,673...178,170,063
Ensembl chr 1:178,148,673...178,165,362
|
|
G |
Hspa5 |
heat shock protein 5 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of HSPA5 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
|
|
G |
Immt |
inner membrane protein, mitochondrial |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of IMMT protein |
CTD |
PMID:32407736 |
|
NCBI chr 6:71,806,200...71,852,250
Ensembl chr 6:71,808,315...71,854,372
|
|
G |
Insig1 |
insulin induced gene 1 |
increases expression |
ISO |
beauvericin results in increased expression of INSIG1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 5:28,276,410...28,283,660
Ensembl chr 5:28,276,361...28,283,660
|
|
G |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ISLR2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 9:58,103,580...58,113,563
Ensembl chr 9:58,103,580...58,111,602
|
|
G |
Itgb1 |
integrin beta 1 (fibronectin receptor beta) |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of ITGB1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 8:129,412,135...129,460,060
Ensembl chr 8:129,412,135...129,459,681
|
|
G |
Klf12 |
Kruppel-like transcription factor 12 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of KLF12 protein |
CTD |
PMID:32407736 |
|
NCBI chr14:100,103,617...100,719,681
Ensembl chr14:100,108,068...100,522,115
|
|
G |
Kpnb1 |
karyopherin subunit beta 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of KPNB1 protein |
CTD |
PMID:32407736 |
|
NCBI chr11:97,050,536...97,078,718
Ensembl chr11:97,050,540...97,078,707
|
|
G |
Krt16 |
keratin 16 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of KRT16 protein |
CTD |
PMID:32407736 |
|
NCBI chr11:100,136,917...100,139,728
Ensembl chr11:100,136,917...100,139,728
|
|
G |
Krt27 |
keratin 27 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of KRT27 protein |
CTD |
PMID:32407736 |
|
NCBI chr11:99,236,391...99,241,944
Ensembl chr11:99,236,391...99,241,930
|
|
G |
Krt5 |
keratin 5 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of KRT5 protein |
CTD |
PMID:32407736 |
|
NCBI chr15:101,615,504...101,621,340
Ensembl chr15:101,615,505...101,621,333
|
|
G |
Krt76 |
keratin 76 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of KRT76 protein |
CTD |
PMID:32407736 |
|
NCBI chr15:101,792,786...101,801,355
Ensembl chr15:101,792,786...101,801,355
|
|
G |
Lamp2 |
lysosomal-associated membrane protein 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of LAMP2 protein |
CTD |
PMID:32407736 |
|
NCBI chr X:37,488,524...37,545,337
Ensembl chr X:37,490,234...37,545,331
|
|
G |
Lat |
linker for activation of T cells |
decreases expression |
ISO |
beauvericin results in decreased expression of LAT mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 7:125,962,999...125,968,877
Ensembl chr 7:125,962,996...125,968,742
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
decreases phosphorylation |
ISO |
beauvericin results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:25178661 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
decreases phosphorylation |
ISO |
beauvericin results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:25178661 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Matn4 |
matrilin 4 |
decreases expression |
ISO |
beauvericin results in decreased expression of MATN4 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 2:164,231,313...164,247,080
Ensembl chr 2:164,231,313...164,247,080
|
|
G |
Mavs |
mitochondrial antiviral signaling protein |
increases expression |
ISO |
beauvericin results in increased expression of MAVS mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 2:131,075,445...131,089,945
Ensembl chr 2:131,075,983...131,089,945
|
|
G |
Med6 |
mediator complex subunit 6 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of MED6 protein |
CTD |
PMID:32407736 |
|
NCBI chr12:81,620,331...81,641,782
Ensembl chr12:81,620,331...81,641,782
|
|
G |
Moap1 |
modulator of apoptosis 1 |
increases expression |
ISO |
beauvericin results in increased expression of MOAP1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr12:102,706,089...102,709,920
Ensembl chr12:102,708,489...102,709,920
|
|
G |
Mrpl12 |
mitochondrial ribosomal protein L12 |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of MRPL12 mRNA [beauvericin co-treated with enniatins] results in decreased expression of MRPL12 mRNA |
CTD |
PMID:29203277 PMID:31100301 |
|
NCBI chr11:120,375,463...120,379,580
Ensembl chr11:120,375,439...120,379,891
|
|
G |
Mrpl4 |
mitochondrial ribosomal protein L4 |
decreases expression |
ISO |
beauvericin results in decreased expression of MRPL4 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 9:20,907,040...20,920,135
Ensembl chr 9:20,914,034...20,920,135
|
|
G |
mt-Atp6 |
ATP synthase 6, mitochondrial |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ATP6 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ATP6 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ATP6 mRNA; [beauvericin co-treated with enniatins] results in increased expression of ATP6 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of ATP6 mRNA; [Plant Extracts co-treated with beauvericin] results in decreased expression of ATP6 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of ATP6 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:7,927...8,607
Ensembl chr MT:7,927...8,607
|
|
G |
mt-Atp8 |
ATP synthase 8, mitochondrial |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ATP8 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of ATP8 mRNA; [beauvericin co-treated with enniatins] affects the expression of ATP8 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ATP8 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of ATP8 mRNA; [Plant Extracts co-treated with beauvericin] results in decreased expression of ATP8 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of ATP8 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:7,766...7,969
Ensembl chr MT:7,766...7,969
|
|
G |
mt-Co1 |
cytochrome c oxidase I, mitochondrial |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of COX1 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of COX1 mRNA; [beauvericin co-treated with enniatins] affects the expression of COX1 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of COX1 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of COX1 mRNA; [Plant Extracts co-treated with beauvericin] results in decreased expression of COX1 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of COX1 mRNA |
CTD |
PMID:31100301 PMID:34015425 |
|
NCBI chr MT:5,328...6,872
Ensembl chr MT:5,328...6,872
|
|
G |
mt-Co3 |
cytochrome c oxidase III, mitochondrial |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of COX3 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of COX3 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of COX3 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of COX3 mRNA; [Plant Extracts co-treated with beauvericin] results in decreased expression of COX3 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of COX3 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:8,607...9,390
Ensembl chr MT:8,607...9,390
|
|
G |
mt-Cytb |
cytochrome b, mitochondrial |
decreases expression |
ISO |
beauvericin results in decreased expression of CYTB mRNA |
CTD |
PMID:29203277 |
|
NCBI chr MT:14,145...15,288
Ensembl chr MT:14,145...15,288
|
|
G |
mt-Nd2 |
NADH dehydrogenase 2, mitochondrial |
decreases expression increases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ND2 mRNA beauvericin results in increased expression of ND2 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND2 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND2 mRNA; [beauvericin co-treated with enniatins] results in increased expression of ND2 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND2 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND2 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in increased expression of ND2 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:3,914...4,951
Ensembl chr MT:3,914...4,951
|
|
G |
mt-Nd3 |
NADH dehydrogenase 3, mitochondrial |
decreases expression increases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ND3 mRNA beauvericin results in increased expression of ND3 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND3 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND3 mRNA; [beauvericin co-treated with enniatins] results in increased expression of ND3 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND3 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND3 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in increased expression of ND3 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:9,459...9,806
Ensembl chr MT:9,459...9,806
|
|
G |
mt-Nd4 |
NADH dehydrogenase 4, mitochondrial |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ND4 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of ND4 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND4 mRNA; [beauvericin co-treated with enniatins] results in increased expression of ND4 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND4 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND4 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of ND4 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:10,167...11,544
Ensembl chr MT:10,167...11,544
|
|
G |
mt-Nd4l |
NADH dehydrogenase 4L, mitochondrial |
decreases expression multiple interactions increases expression |
ISO |
beauvericin results in decreased expression of ND4L mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND4L mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND4L mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND4L mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND4L mRNA beauvericin results in increased expression of ND4L mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:9,877...10,173
Ensembl chr MT:9,877...10,173
|
|
G |
mt-Nd5 |
NADH dehydrogenase 5, mitochondrial |
decreases expression increases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ND5 mRNA beauvericin results in increased expression of ND5 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND5 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND5 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND5 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND5 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:11,742...13,565
Ensembl chr MT:11,742...13,565
|
|
G |
mt-Nd6 |
NADH dehydrogenase 6, mitochondrial |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ND6 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of ND6 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND6 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND6 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND6 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:13,552...14,070
Ensembl chr MT:13,552...14,070
|
|
G |
mt-Rnr2 |
16S rRNA, mitochondrial |
increases expression multiple interactions |
ISO |
beauvericin results in increased expression of RNR2 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of RNR2 mRNA; [beauvericin co-treated with enniatins] affects the expression of RNR2 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of RNR2 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of RNR2 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of RNR2 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:1,094...2,675
Ensembl chr MT:1,094...2,675
|
|
G |
Mtrf1l |
mitochondrial translational release factor 1-like |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of MTRF1L protein |
CTD |
PMID:32407736 |
|
NCBI chr10:5,760,151...5,775,015
Ensembl chr10:5,761,887...5,773,910
|
|
G |
Myo18a |
myosin XVIIIA |
increases expression |
ISO |
beauvericin results in increased expression of MYO18A mRNA |
CTD |
PMID:29203277 |
|
NCBI chr11:77,654,066...77,756,806
Ensembl chr11:77,654,072...77,756,806
|
|
G |
Nars1 |
asparaginyl-tRNA synthetase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of NARS1 protein |
CTD |
PMID:32407736 |
|
NCBI chr18:64,632,726...64,649,586
Ensembl chr18:64,632,718...64,649,723
|
|
G |
Nars2 |
asparaginyl-tRNA synthetase 2 (mitochondrial)(putative) |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of NARS2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:96,600,698...96,725,606
Ensembl chr 7:96,600,712...96,713,965
|
|
G |
Ndrg1 |
N-myc downstream regulated gene 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of NDRG1 protein |
CTD |
PMID:32407736 |
|
NCBI chr15:66,801,167...66,841,490
Ensembl chr15:66,801,167...66,841,489
|
|
G |
Nlrp1a |
NLR family, pyrin domain containing 1A |
increases expression |
ISO |
beauvericin results in increased expression of NLRP1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr11:70,982,023...71,035,780
Ensembl chr11:70,983,062...71,035,530
|
|
G |
Nod1 |
nucleotide-binding oligomerization domain containing 1 |
increases expression |
ISO |
beauvericin results in increased expression of NOD1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 6:54,900,927...54,949,655
Ensembl chr 6:54,900,934...54,949,597
|
|
G |
Nol3 |
nucleolar protein 3 (apoptosis repressor with CARD domain) |
increases expression |
ISO |
beauvericin results in increased expression of NOL3 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 8:106,002,777...106,008,571
Ensembl chr 8:106,002,772...106,008,571
|
|
G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of NQO1 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
|
|
G |
Nudt1 |
nudix hydrolase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of NUDT1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 5:140,307,375...140,323,892
Ensembl chr 5:140,307,411...140,323,892
|
|
G |
Oga |
O-GlcNAcase |
increases expression |
ISO |
beauvericin results in increased expression of OGA mRNA |
CTD |
PMID:29203277 |
|
NCBI chr19:45,738,698...45,772,274
Ensembl chr19:45,738,698...45,772,276
|
|
G |
Ogt |
O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase) |
increases expression |
ISO |
beauvericin results in increased expression of OGT mRNA |
CTD |
PMID:29203277 |
|
NCBI chr X:100,683,617...100,727,957
Ensembl chr X:100,683,666...100,727,957
|
|
G |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
multiple interactions increases expression |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of OSGIN1 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of OSGIN1 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of OSGIN1 mRNA beauvericin results in increased expression of OSGIN1 mRNA |
CTD |
PMID:31100301 PMID:34015425 |
|
NCBI chr 8:120,160,874...120,172,996
Ensembl chr 8:120,160,863...120,172,995
|
|
G |
Ostc |
oligosaccharyltransferase complex subunit (non-catalytic) |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of OSTC protein |
CTD |
PMID:32407736 |
|
NCBI chr 3:130,489,566...130,503,093
Ensembl chr 3:130,489,561...130,503,093
|
|
G |
Parvg |
parvin, gamma |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PARVG protein |
CTD |
PMID:32407736 |
|
NCBI chr15:84,208,388...84,227,179
Ensembl chr15:84,208,227...84,227,179
|
|
G |
Pawr |
PRKC, apoptosis, WT1, regulator |
decreases expression |
ISO |
beauvericin results in decreased expression of PAWR mRNA |
CTD |
PMID:29203277 |
|
NCBI chr10:108,168,050...108,250,708
Ensembl chr10:108,167,982...108,250,101
|
|
G |
Pdcd11 |
programmed cell death 11 |
decreases expression |
ISO |
beauvericin results in decreased expression of PDCD11 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr19:47,079,183...47,119,585
Ensembl chr19:47,079,207...47,120,304
|
|
G |
Pdcd2 |
programmed cell death 2 |
decreases expression |
ISO |
beauvericin results in decreased expression of PDCD2 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr17:15,739,472...15,747,560
Ensembl chr17:15,739,470...15,747,563
|
|
G |
Pdcd2l |
programmed cell death 2-like |
increases expression |
ISO |
beauvericin results in increased expression of PDCD2L mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 7:33,883,922...33,896,154
Ensembl chr 7:33,883,924...33,896,086
|
|
G |
Pdcd4 |
programmed cell death 4 |
decreases expression |
ISO |
beauvericin results in decreased expression of PDCD4 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr19:53,880,662...53,926,024
Ensembl chr19:53,880,662...53,918,291
|
|
G |
Pdcd5 |
programmed cell death 5 |
increases expression |
ISO |
beauvericin results in increased expression of PDCD5 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 7:35,341,410...35,346,907
Ensembl chr 7:35,341,407...35,346,946
|
|
G |
Pdcd6ip |
programmed cell death 6 interacting protein |
increases expression |
ISO |
beauvericin results in increased expression of PDCD6IP mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 9:113,480,812...113,537,457
Ensembl chr 9:113,480,812...113,537,327
|
|
G |
Pdia4 |
protein disulfide isomerase associated 4 |
decreases expression |
ISO |
beauvericin results in decreased expression of PDIA4 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 6:47,773,075...47,790,446
Ensembl chr 6:47,773,075...47,790,364
|
|
G |
Pfn1 |
profilin 1 |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of PFN1 mRNA [beauvericin co-treated with enniatins] results in increased expression of PFN1 protein |
CTD |
PMID:29203277 PMID:32407736 |
|
NCBI chr11:70,542,670...70,547,625
Ensembl chr11:70,542,676...70,545,470
|
|
G |
Pgam1 |
phosphoglycerate mutase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PGAM1 protein |
CTD |
PMID:32407736 |
|
NCBI chr19:41,900,310...41,907,104
Ensembl chr19:41,900,362...41,907,099
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PGK1 protein |
CTD |
PMID:32407736 |
|
NCBI chr X:105,230,706...105,247,305
Ensembl chr X:105,230,706...105,247,305
|
|
G |
Phgdh |
3-phosphoglycerate dehydrogenase |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PHGDH protein |
CTD |
PMID:32407736 |
|
NCBI chr 3:98,220,487...98,247,285
Ensembl chr 3:98,220,486...98,247,306
|
|
G |
Phka2 |
phosphorylase kinase alpha 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of PHKA2 protein |
CTD |
PMID:32407736 |
|
NCBI chr X:159,284,900...159,384,772
Ensembl chr X:159,285,162...159,381,874
|
|
G |
Pidd1 |
p53 induced death domain protein 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of PIDD1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 7:141,018,026...141,027,477
Ensembl chr 7:141,018,026...141,023,938
|
|
G |
Plk1 |
polo like kinase 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of PLK1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 7:121,758,658...121,769,107
Ensembl chr 7:121,758,662...121,769,096
|
|
G |
Pls3 |
plastin 3 (T-isoform) |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of PLS3 protein |
CTD |
PMID:32407736 |
|
NCBI chr X:74,829,259...74,918,788
Ensembl chr X:74,829,260...74,918,788
|
|
G |
Potefam1 |
POTE ankyrin domain family member 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of POTEJ protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:110,880,755...111,059,948
Ensembl chr 2:110,880,755...111,059,948
|
|
G |
Ppa1 |
pyrophosphatase (inorganic) 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PPA1 protein |
CTD |
PMID:32407736 |
|
NCBI chr10:61,484,400...61,509,944
Ensembl chr10:61,484,331...61,509,947
|
|
G |
Ppan |
peter pan homolog |
decreases expression |
ISO |
beauvericin results in decreased expression of PPAN mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 9:20,799,471...20,803,475
Ensembl chr 9:20,799,471...20,803,474
|
|
G |
Ppib |
peptidylprolyl isomerase B |
decreases expression |
ISO |
beauvericin results in decreased expression of PPIB mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 9:65,967,451...65,973,911
Ensembl chr 9:65,967,504...65,973,905
|
|
G |
Ppp1r14b |
protein phosphatase 1, regulatory inhibitor subunit 14B |
decreases expression |
ISO |
beauvericin results in decreased expression of PPP1R14B mRNA |
CTD |
PMID:29203277 |
|
NCBI chr19:6,952,416...6,954,692
Ensembl chr19:6,952,336...6,954,692
|
|
G |
Ppt1 |
palmitoyl-protein thioesterase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of PPT1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 4:122,729,879...122,752,968
Ensembl chr 4:122,730,035...122,752,968
|
|
G |
Prkca |
protein kinase C, alpha |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PRKCA protein |
CTD |
PMID:32407736 |
|
NCBI chr11:107,824,213...108,237,360
Ensembl chr11:107,824,213...108,234,754
|
|
G |
Psma5 |
proteasome subunit alpha 5 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PSMA5 protein |
CTD |
PMID:32407736 |
|
NCBI chr 3:108,164,242...108,187,268
Ensembl chr 3:108,164,242...108,187,290
|
|
G |
Psme4 |
proteasome (prosome, macropain) activator subunit 4 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of PSME4 protein |
CTD |
PMID:32407736 |
|
NCBI chr11:30,721,753...30,831,150
Ensembl chr11:30,721,726...30,830,361
|
|
G |
Ptges3 |
prostaglandin E synthase 3 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PTGES3 protein |
CTD |
PMID:32407736 |
|
NCBI chr10:127,894,851...127,913,123
Ensembl chr10:127,894,823...127,913,141
|
|
G |
Ptprc |
protein tyrosine phosphatase receptor type C |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PTPRC protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:137,990,601...138,103,491
Ensembl chr 1:137,990,599...138,103,446
|
|
G |
Rab11fip5 |
RAB11 family interacting protein 5 (class I) |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of RAB11FIP5 protein |
CTD |
PMID:32407736 |
|
NCBI chr 6:85,311,944...85,351,663
Ensembl chr 6:85,311,944...85,351,616
|
|
G |
Rab5a |
RAB5A, member RAS oncogene family |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of RAB5A protein |
CTD |
PMID:32407736 |
|
NCBI chr17:53,786,262...53,814,706
Ensembl chr17:53,786,262...53,814,708
|
|
G |
Rac3 |
Rac family small GTPase 3 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of RAC3 protein |
CTD |
PMID:32407736 |
|
NCBI chr11:120,612,294...120,614,795
Ensembl chr11:120,612,296...120,614,795
|
|
G |
Rap1a |
RAS-related protein 1a |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of RAP1A protein |
CTD |
PMID:32407736 |
|
NCBI chr 3:105,634,576...105,708,740
Ensembl chr 3:105,634,583...105,708,652
|
|
G |
Relt |
RELT tumor necrosis factor receptor |
decreases expression |
ISO |
beauvericin results in decreased expression of RELT mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 7:100,495,054...100,512,690
Ensembl chr 7:100,495,054...100,512,653
|
|
G |
Rp2 |
retinitis pigmentosa 2 homolog |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of RP2 protein |
CTD |
PMID:32407736 |
|
NCBI chr X:20,230,778...20,271,873
Ensembl chr X:20,230,720...20,271,892
|
|
G |
Rpl37a |
ribosomal protein L37a |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of RPL37A protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:72,750,426...72,752,972
Ensembl chr 1:72,750,449...72,752,972
|
|
G |
Rpl5 |
ribosomal protein L5 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of RPL5 protein |
CTD |
PMID:32407736 |
|
NCBI chr 5:108,048,388...108,056,871
Ensembl chr 5:108,048,368...108,056,871
|
|
G |
Rpl8 |
ribosomal protein L8 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of RPL8 protein |
CTD |
PMID:32407736 |
|
NCBI chr15:76,788,271...76,790,518
Ensembl chr15:76,788,278...76,790,514
|
|
G |
Rxra |
retinoid X receptor alpha |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of RXRA protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:27,566,457...27,653,331
Ensembl chr 2:27,566,452...27,652,969
|
|
G |
Scml2 |
Scm polycomb group protein like 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of SCML2 protein |
CTD |
PMID:32407736 |
|
NCBI chr X:159,865,521...160,041,214
Ensembl chr X:159,865,521...160,041,209
|
|
G |
Sdf2l1 |
stromal cell-derived factor 2-like 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of SDF2L1 protein |
CTD |
PMID:32407736 |
|
NCBI chr16:16,948,002...16,950,247
Ensembl chr16:16,948,002...16,950,247
|
|
G |
Sdr42e2 |
short chain dehydrogenase/reductase family 42E, member 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of SDR42E2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:120,408,853...120,431,122
Ensembl chr 7:120,411,588...120,430,416
|
|
G |
Sec13 |
SEC13 homolog, nuclear pore and COPII coat complex component |
decreases expression |
ISO |
beauvericin results in decreased expression of SEC13 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 6:113,705,013...113,717,642
Ensembl chr 6:113,705,023...113,717,704
|
|
G |
Siva1 |
SIVA1, apoptosis-inducing factor |
decreases expression |
ISO |
beauvericin results in decreased expression of SIVA1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr12:112,611,262...112,615,586
Ensembl chr12:112,611,113...112,615,583
|
|
G |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of SLC1A5 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:16,515,259...16,532,199
Ensembl chr 7:16,515,265...16,532,199
|
|
G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of SLC2A1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 4:118,966,001...118,994,527
Ensembl chr 4:118,965,908...118,995,180
|
|
G |
Slc3a2 |
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of SLC3A2 protein |
CTD |
PMID:32407736 |
|
NCBI chr19:8,684,931...8,700,733
Ensembl chr19:8,684,246...8,700,733
|
|
G |
Snrpd2 |
small nuclear ribonucleoprotein D2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of SNRPD2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:18,883,370...18,886,659
Ensembl chr 7:18,883,647...18,887,467
|
|
G |
Snrpd3 |
small nuclear ribonucleoprotein D3 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of SNRPD3 protein |
CTD |
PMID:32407736 |
|
NCBI chr10:75,353,852...75,371,300
Ensembl chr10:75,353,385...75,373,215
|
|
G |
Src |
Rous sarcoma oncogene |
decreases activity |
ISO |
beauvericin results in decreased activity of SRC protein |
CTD |
PMID:25178661 |
|
NCBI chr 2:157,265,828...157,313,758
Ensembl chr 2:157,260,364...157,313,782
|
|
G |
Srm |
spermidine synthase |
decreases expression |
ISO |
beauvericin results in decreased expression of SRM mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 4:148,675,970...148,679,076
Ensembl chr 4:148,675,960...148,679,450
|
|
G |
Srsf7 |
serine and arginine-rich splicing factor 7 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of SRSF7 protein |
CTD |
PMID:32407736 |
|
NCBI chr17:80,507,509...80,514,734
Ensembl chr17:80,507,509...80,514,736
|
|
G |
Srxn1 |
sulfiredoxin 1 homolog (S. cerevisiae) |
multiple interactions decreases expression |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of SRXN1 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of SRXN1 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of SRXN1 mRNA; [Plant Extracts co-treated with beauvericin] results in decreased expression of SRXN1 mRNA beauvericin results in decreased expression of SRXN1 mRNA |
CTD |
PMID:31100301 PMID:34015425 |
|
NCBI chr 2:151,946,738...151,953,296
Ensembl chr 2:151,947,436...151,953,296
|
|
G |
Ssbp1 |
single-stranded DNA binding protein 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of SSBP1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 6:40,448,302...40,458,757
Ensembl chr 6:40,448,286...40,461,634
|
|
G |
Tbc1d2b |
TBC1 domain family, member 2B |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TBC1D2B protein |
CTD |
PMID:32407736 |
|
NCBI chr 9:90,084,100...90,152,861
Ensembl chr 9:90,084,080...90,152,857
|
|
G |
Tcn2 |
transcobalamin 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TCN2 protein |
CTD |
PMID:32407736 |
|
NCBI chr11:3,867,077...3,882,078
Ensembl chr11:3,867,192...3,882,159
|
|
G |
Tcp11l1 |
t-complex 11 like 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TCP11L1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:104,497,587...104,542,525
Ensembl chr 2:104,487,633...104,542,514
|
|
G |
Tcp11l2 |
t-complex 11 (mouse) like 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TCP11L2 protein |
CTD |
PMID:32407736 |
|
NCBI chr10:84,412,811...84,450,219
Ensembl chr10:84,412,490...84,450,223
|
|
G |
Thyn1 |
thymocyte nuclear protein 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of THYN1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 9:26,910,950...26,918,632
Ensembl chr 9:26,911,006...26,918,632
|
|
G |
Timm9 |
translocase of inner mitochondrial membrane 9 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TIMM9 protein |
CTD |
PMID:32407736 |
|
NCBI chr12:71,169,946...71,183,476
Ensembl chr12:71,169,947...71,183,458
|
|
G |
Tk1 |
thymidine kinase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TK1 protein |
CTD |
PMID:32407736 |
|
NCBI chr11:117,706,345...117,716,913
Ensembl chr11:117,706,352...117,716,918
|
|
G |
Tmem263 |
transmembrane protein 263 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of TMEM263 protein |
CTD |
PMID:32407736 |
|
NCBI chr10:84,938,491...84,953,611
Ensembl chr10:84,938,491...84,956,482
|
|
G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
decreases expression |
ISO |
beauvericin results in decreased expression of TNFSF10 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 3:27,371,226...27,393,814
Ensembl chr 3:27,371,177...27,396,576
|
|
G |
Tomm22 |
translocase of outer mitochondrial membrane 22 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TOMM22 protein |
CTD |
PMID:32407736 |
|
NCBI chr15:79,555,069...79,557,063
Ensembl chr15:79,555,062...79,557,601
|
|
G |
Tomm7 |
translocase of outer mitochondrial membrane 7 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TOMM7 protein |
CTD |
PMID:32407736 |
|
NCBI chr 5:24,043,942...24,049,143
Ensembl chr 5:24,043,942...24,049,159
|
|
G |
Tuba1b |
tubulin, alpha 1B |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of TUBA1B protein |
CTD |
PMID:32407736 |
|
NCBI chr15:98,829,310...98,832,271
Ensembl chr15:98,829,306...98,832,446
|
|
G |
Tubb3 |
tubulin, beta 3 class III |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of TUBB3 protein |
CTD |
PMID:32407736 |
|
NCBI chr 8:124,138,292...124,148,754
Ensembl chr 8:124,138,163...124,148,754
|
|
G |
Tubb4a |
tubulin, beta 4A class IVA |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of TUBB4A protein |
CTD |
PMID:32407736 |
|
NCBI chr17:57,387,061...57,394,600
Ensembl chr17:57,387,066...57,394,782
|
|
G |
Tubb4b |
tubulin, beta 4B class IVB |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of TUBB4B protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:25,112,170...25,114,714
Ensembl chr 2:25,112,172...25,114,714
|
|
G |
Tubb5 |
tubulin, beta 5 class I |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of TUBB protein |
CTD |
PMID:32407736 |
|
NCBI chr17:36,144,812...36,149,193
Ensembl chr17:36,144,813...36,149,198
|
|
G |
Txnip |
thioredoxin interacting protein |
increases expression multiple interactions decreases expression |
ISO |
beauvericin results in increased expression of TXNIP mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of TXNIP mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of TXNIP mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of TXNIP mRNA beauvericin results in decreased expression of TXNIP mRNA |
CTD |
PMID:29203277 PMID:34015425 |
|
NCBI chr 3:96,465,273...96,469,173
Ensembl chr 3:96,465,273...96,469,199
|
|
G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
multiple interactions decreases expression |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of UCP2 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of UCP2 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of UCP2 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of UCP2 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of UCP2 mRNA beauvericin results in decreased expression of UCP2 mRNA |
CTD |
PMID:31100301 PMID:34015425 |
|
NCBI chr 7:100,142,565...100,148,832
Ensembl chr 7:100,142,544...100,151,227
|
|
G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of UCP3 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr 7:100,122,198...100,135,639
Ensembl chr 7:100,122,197...100,135,639
|
|
G |
Ybx1 |
Y box protein 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of YBX1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 4:119,134,524...119,153,462
Ensembl chr 4:119,135,178...119,151,801
|
|
G |
Ybx3 |
Y box protein 3 |
decreases expression |
ISO |
beauvericin results in decreased expression of YBX3 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 6:131,341,821...131,365,413
Ensembl chr 6:131,341,818...131,365,439
|
|
G |
Ykt6 |
YKT6 v-SNARE homolog (S. cerevisiae) |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of YKT6 protein |
CTD |
PMID:32407736 |
|
NCBI chr11:5,905,779...5,917,780
Ensembl chr11:5,905,693...5,917,780
|
|
|
G |
Abcc2 |
ATP-binding cassette, sub-family member 2 |
increases activity |
ISO |
Carbon Monoxide results in increased activity of ABCC2 protein |
CTD |
PMID:13678533 |
|
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions increases expression |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of AKT1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of NOS3 protein]; [Carbon Monoxide results in increased expression of ADIPOQ protein] inhibits the reaction [TNF protein results in increased activity of CASP3 protein]; [Carbon Monoxide results in increased expression of ADIPOQ protein] inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; [Carbon Monoxide results in increased expression of ADIPOQ protein] inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; [Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of AKT1 protein; [Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of NOS3 protein [Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased expression of PECAM1 protein; Carbon Monoxide results in increased expression of ADIPOQ protein |
CTD |
PMID:19356108 |
|
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
|
|
G |
Adm |
adrenomedullin |
increases expression |
ISO |
Carbon Monoxide results in increased expression of ADM mRNA; Carbon Monoxide results in increased expression of ADM protein |
CTD |
PMID:10666155 |
|
NCBI chr 7:110,226,864...110,229,027
Ensembl chr 7:110,226,868...110,229,027
|
|
G |
Agr2 |
anterior gradient 2 |
multiple interactions |
EXP |
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of AGR2 mRNA |
CTD |
PMID:29621558 |
|
NCBI chr12:36,042,924...36,054,080
Ensembl chr12:36,042,906...36,054,086
|
|
G |
Agt |
angiotensinogen |
decreases response to substance |
EXP |
AGT protein results in decreased susceptibility to Carbon Monoxide |
CTD |
PMID:18174886 |
|
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
multiple interactions increases phosphorylation |
EXP ISO |
AKT1 protein affects the reaction [Carbon Monoxide results in increased localization of NRF1 protein]; Carbon Monoxide inhibits the reaction [Doxorubicin results in decreased phosphorylation of AKT1 protein]; Carbon Monoxide results in increased phosphorylation of and results in increased activity of AKT1 protein; CAT protein inhibits the reaction [Carbon Monoxide results in increased phosphorylation of AKT1 protein] Carbon Monoxide inhibits the reaction [IL18 protein results in decreased phosphorylation of AKT1 protein] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of AKT1 protein]; [Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of AKT1 protein; Carbon Monoxide results in increased phosphorylation of and results in increased activity of AKT1 protein; CAT protein inhibits the reaction [Carbon Monoxide results in increased phosphorylation of and results in increased activity of AKT1 protein] |
CTD |
PMID:17179207 PMID:18037988 PMID:18215737 PMID:18845810 PMID:19356108 |
|
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Alad |
aminolevulinate, delta-, dehydratase |
increases activity multiple interactions |
ISO |
Carbon Monoxide results in increased activity of ALAD protein Carbon Monoxide inhibits the reaction [[Phenobarbital co-treated with bromobenzene] results in decreased activity of ALAD protein] |
CTD |
PMID:1032310 PMID:6740708 |
|
NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155
|
|
G |
Areg |
amphiregulin |
multiple interactions |
EXP |
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in decreased expression of AREG mRNA |
CTD |
PMID:29621558 |
|
NCBI chr 5:91,287,458...91,296,291
Ensembl chr 5:91,287,458...91,296,291
|
|
G |
Bach1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
decreases phosphorylation |
EXP |
Carbon Monoxide results in decreased phosphorylation of BACH1 protein |
CTD |
PMID:18845810 |
|
NCBI chr16:87,495,842...87,530,234
Ensembl chr16:87,495,833...87,530,234
|
|
G |
Bad |
BCL2-associated agonist of cell death |
multiple interactions |
EXP |
Carbon Monoxide inhibits the reaction [Doxorubicin results in decreased phosphorylation of BAD protein] |
CTD |
PMID:18037988 |
|
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
|
|
G |
Bcl2a1b |
B cell leukemia/lymphoma 2 related protein A1b |
multiple interactions |
ISO |
BCL2A1 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]; MAPK14 protein affects the reaction [BCL2A1 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]] |
CTD |
PMID:11880364 |
|
NCBI chr 9:89,081,326...89,089,891
Ensembl chr 9:89,081,262...89,089,880
|
|
G |
Bdnf |
brain derived neurotrophic factor |
multiple interactions decreases expression |
ISO |
Carbon Monoxide results in decreased expression of and results in decreased secretion of BDNF protein Carbon Monoxide results in decreased expression of BDNF mRNA |
CTD |
PMID:27113706 |
|
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
multiple interactions |
ISO |
BIRC3 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]; MAPK14 protein affects the reaction [BIRC3 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]] |
CTD |
PMID:11880364 |
|
NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression increases activity |
ISO |
[Carbon Monoxide results in increased expression of ADIPOQ protein] inhibits the reaction [TNF protein results in increased activity of CASP3 protein]; Carbon Monoxide inhibits the reaction [Carbon Tetrachloride results in increased activity of CASP3 protein]; Carbon Monoxide results in increased cleavage of and results in increased activity of CASP3 protein; Hemin inhibits the reaction [Carbon Monoxide results in increased cleavage of and results in increased activity of CASP3 protein]; sulforaphane inhibits the reaction [Carbon Monoxide results in increased expression of CASP3 mRNA]; tin protoporphyrin IX inhibits the reaction [Hemin inhibits the reaction [Carbon Monoxide results in increased cleavage of and results in increased activity of CASP3 protein]] Carbon Monoxide results in increased expression of CASP3 protein [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of CASP3 mRNA Carbon Monoxide results in increased activity of CASP3 protein |
CTD |
PMID:17173083 PMID:19356108 PMID:19520142 PMID:25562542 PMID:31268311 PMID:37860845 More...
|
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp7 |
caspase 7 |
increases activity |
ISO |
Carbon Monoxide results in increased activity of CASP7 protein |
CTD |
PMID:25562542 |
|
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
|
|
G |
Casp8 |
caspase 8 |
increases activity multiple interactions |
ISO |
Carbon Monoxide results in increased activity of CASP8 protein [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of CASP8 mRNA |
CTD |
PMID:25562542 PMID:31268311 |
|
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Casp9 |
caspase 9 |
increases activity increases expression multiple interactions |
ISO |
Carbon Monoxide results in increased activity of CASP9 protein Carbon Monoxide results in increased expression of CASP9 mRNA; Carbon Monoxide results in increased expression of CASP9 protein sulforaphane inhibits the reaction [Carbon Monoxide results in increased expression of CASP9 mRNA]; sulforaphane inhibits the reaction [Carbon Monoxide results in increased expression of CASP9 protein] [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of CASP9 mRNA |
CTD |
PMID:25562542 PMID:31268311 PMID:37860845 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Cat |
catalase |
multiple interactions decreases expression |
EXP ISO |
CAT protein inhibits the reaction [Carbon Monoxide results in increased localization of NFE2L2 protein]; CAT protein inhibits the reaction [Carbon Monoxide results in increased phosphorylation of AKT1 protein] Carbon Monoxide results in decreased expression of CAT protein CAT protein inhibits the reaction [Carbon Monoxide promotes the reaction [NRF1 protein binds to TFAM promoter]]; CAT protein inhibits the reaction [Carbon Monoxide results in increased phosphorylation of and results in increased activity of AKT1 protein]; NFE2L2 protein inhibits the reaction [Carbon Monoxide results in decreased expression of CAT protein] |
CTD |
PMID:17179207 PMID:18845810 PMID:34032369 |
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Ccl1 |
C-C motif chemokine ligand 1 |
multiple interactions |
EXP |
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in decreased expression of CCL1 mRNA |
CTD |
PMID:29621558 |
|
NCBI chr11:82,067,492...82,070,638
Ensembl chr11:82,067,483...82,196,516
|
|
G |
Cd86 |
CD86 antigen |
decreases expression |
ISO |
Carbon Monoxide results in decreased expression of CD86 protein |
CTD |
PMID:12201358 |
|
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
|
|
G |
Clca1 |
chloride channel accessory 1 |
multiple interactions |
EXP |
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of CLCA1 mRNA |
CTD |
PMID:29621558 |
|
NCBI chr 3:144,710,298...144,738,537
Ensembl chr 3:144,709,578...144,738,537
|
|
G |
Col11a1 |
collagen, type XI, alpha 1 |
multiple interactions |
EXP |
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of COL11A1 mRNA |
CTD |
PMID:29621558 |
|
NCBI chr 3:113,823,933...114,014,405
Ensembl chr 3:113,824,189...114,014,367
|
|
G |
Crp |
C-reactive protein, pentraxin-related |
increases expression |
ISO |
Carbon Monoxide results in increased expression of CRP protein |
CTD |
PMID:18629312 |
|
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
|
|
G |
Cxcl11 |
chemokine (C-X-C motif) ligand 11 |
multiple interactions |
EXP |
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of CXCL11 mRNA |
CTD |
PMID:29621558 |
|
NCBI chr 5:92,507,403...92,511,155
Ensembl chr 5:92,507,403...92,513,344
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
Carbon Monoxide inhibits the reaction [CYP1A1 protein results in increased reduction of sodium chromate(VI)] |
CTD |
PMID:1903091 |
|
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions |
EXP |
Carbon Monoxide promotes the reaction [1-ethynylpyrene results in increased expression of CYP1B1 mRNA] |
CTD |
PMID:10581206 |
|
NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases activity multiple interactions |
ISO |
Carbon Monoxide results in decreased activity of CYP2E1 protein Carbon Monoxide inhibits the reaction [CYP2E1 protein results in increased reduction of sodium chromate(VI)] |
CTD |
PMID:1903091 PMID:15036350 |
|
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
|
|
G |
Dnm1l |
dynamin 1-like |
multiple interactions increases expression |
ISO |
sulforaphane inhibits the reaction [Carbon Monoxide results in increased expression of DNM1L protein] |
CTD |
PMID:37860845 |
|
NCBI chr16:16,130,092...16,176,863
Ensembl chr16:16,130,094...16,176,823
|
|
G |
Duox2 |
dual oxidase 2 |
decreases expression increases expression |
ISO |
Carbon Monoxide results in decreased expression of DUOX2 protein Carbon Monoxide results in increased expression of DUOX2 mRNA |
CTD |
PMID:29223502 |
|
NCBI chr 2:122,109,727...122,129,221
Ensembl chr 2:122,109,728...122,128,930
|
|
G |
Edn1 |
endothelin 1 |
increases expression multiple interactions |
EXP ISO |
Carbon Monoxide results in increased expression of EDN1 mRNA Carbon Monoxide deficiency promotes the reaction [HMOX2 mutant form results in increased expression of EDN1 protein] Carbon Monoxide results in increased expression of EDN1 mRNA; Carbon Monoxide results in increased expression of EDN1 protein |
CTD |
PMID:11781074 PMID:12969895 PMID:20197249 |
|
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions |
EXP |
Carbon Monoxide inhibits the reaction [Lipopolysaccharides results in increased expression of EGR1 mRNA]; Carbon Monoxide inhibits the reaction [Lipopolysaccharides results in increased expression of EGR1 protein]; UCP2 protein promotes the reaction [Carbon Monoxide inhibits the reaction [Lipopolysaccharides results in increased expression of EGR1 protein]] |
CTD |
PMID:22046279 |
|
NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
|
|
G |
Eno2 |
enolase 2, gamma neuronal |
increases secretion |
ISO |
Carbon Monoxide results in increased secretion of ENO2 protein |
CTD |
PMID:34533065 |
|
NCBI chr 6:124,737,018...124,746,489
Ensembl chr 6:124,737,016...124,746,636
|
|
G |
Epo |
erythropoietin |
increases expression |
ISO |
Carbon Monoxide results in increased expression of EPO mRNA; Carbon Monoxide results in increased expression of EPO protein |
CTD |
PMID:9263988 |
|
NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
|
|
G |
Ero1a |
endoplasmic reticulum oxidoreductase 1 alpha |
increases expression |
ISO |
Carbon Monoxide results in increased expression of ERO1A mRNA |
CTD |
PMID:12752442 |
|
NCBI chr14:45,520,544...45,556,029
Ensembl chr14:45,520,544...45,556,228
|
|
G |
Ezr |
ezrin |
multiple interactions |
ISO |
[[Vehicle Emissions results in increased abundance of Air Pollutants] which results in increased abundance of Carbon Monoxide] which results in decreased expression of EZR protein |
CTD |
PMID:37141245 |
|
NCBI chr17:7,005,530...7,050,179
Ensembl chr17:7,005,440...7,050,183
|
|
G |
Fgb |
fibrinogen beta chain |
multiple interactions |
| |